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An estimated one third of the world’s population is infected with 
Mycobacterium tuberculosis (Mtb) and suppresses the pathogen’s 
replication without eradicating it, thereby remaining at risk for developing 
active tuberculosis (TB). It is not clear how Mtb survives, potentially for 
decades, in a hostile host environment. Respiration of nitrate to nitrite 
could help Mtb to survive in hypoxic tissues, but was not thought to be 
significant at physiologic oxygen tensions, nor was the resultant nitrite 
considered consequential to Mtb’s physiology. Here, we found that Mtb 
infecting human macrophages in vitro produces copious nitrite at 
physiologic oxygen tensions. The nitrite impacts Mtb in diverse ways, 
slowing its growth, reducing its consumption of ATP, regulating its 
survival following treatment with isoniazid and hydrogen peroxide, and 
remodeling its transcriptome in a manner distinct from that of nitric oxide. 
Thus, respiration of nitrate and adaptation to nitrite are likely to play a 
prominent role in Mtb’s pathophysiology, whether or not the Mtb resides 
in hypoxic sites.  
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CHAPTER 1 
INTRODUCTION  
 
Mycobacterium tuberculosis (Mtb) is the second leading cause of 
death worldwide from a single infectious pathogen (1). Despite the 
induction of a potent immune response, Mtb is not eradicated and survives 
to establish lifelong disease. Furthermore, months of multidrug 
chemotherapy are required to treat patients with tuberculosis (TB) (2). 
How Mtb survives the arsenal of toxic small molecules that are products 
of an active immune response, and why months of multidrug 
chemotherapy are required to treat TB, remain active areas of 
investigation.  
 
The toxic molecules produced by an active immune response. 
 Humans have co-evolved with Mtb over millennia and are its only 
known natural host (3, 4). Infection with Mtb begins with the inhalation 
of droplet nuclei containing Mtb, which arise from infected individuals 
and become airborne (5, 6). Within the lung alveoli of a newly infected 
host, Mtb is confined within the phagosomes of resident macrophages. 
Once activated by interferon gamma (IFNγ), these phagosomal 
compartments fuse with adjacent intracellular lysosomes and acidify (7). 
IFNγ also triggers the assembly and recruitment of enzymes responsible 
for the production of reactive nitrogen and oxygen species (RNS and 
ROS, respectively). Examples of RNS include, nitric oxide (•NO), 
nitrogen dioxide (•NO2) and nitrite (NO2-) and examples of ROS are 
superoxide (O2•-), hydrogen peroxide (H2O2) and hydroxyl radical (•OH) 
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(8, 9). Nitrate (NO3-) can give rise to the above RNS within humans, 
however, this primarily requires enzymatic reduction by nitrate reductase 
enzymes expressed by oral commensal bacteria (10). This is described in 
greater detail below. 
Despite exposure to these potentially lethal host products, Mtb 
expresses enzymes that detoxify ROS and RNS directly, as well as 
enzymes that repair mycobacterial proteins and DNA damaged by these 
toxic molecules. For example, enzymes which degrade ROS and/or RNS 
include Mtb’s catalase/peroxidase KatG, the superoxide dismutases SodA 
and SodC, an NADPH dependent peroxidase/peroxynitrite reductase 
encoded by ahpC, ahpD, lpdC and dlaT and the truncated hemoglobins 
trHbO and trHbN. The majority of these proteins have been shown to 
contribute to mycobacterial virulence (9, 11, 12). Methionine sulphoxide 
reductases, MsrA and MsrB, repair the ROS and RNS mediated oxidation 
of methionine residues and UvrB, a DNA repair protein contributes to 
resistance against both ROI and RNI in vivo (13, 14). Furthermore, 
mycobacteria synthesize mycothiol rather than glutathione, which serves 
as a dominant intracellular antioxidant. Mycobacteria unable to synthesize 
mycothiol are less able to survive treatment with ROS and RNS (15). 
 
The host exploits the toxicity and essentiality of transition metals  
Every living organism depends upon transition metals for growth, 
DNA replication and metabolic energy production. Moreover, these 
essential metals are required for the catalytic function of many of the 
enzymes involved in resistance to ROS and RNS mediated oxidative 
stress (16). Iron, the most abundant transition metal within human tissue, 
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is actively sequestered away from microbial pathogens by host proteins. 
Infected human phagocytes stimulated with IFNγ repressed the expression 
of transferrin and the intracellular iron storage protein, ferritin thus 
reducing the total concentration of intracellular iron and limiting 
intracellular bacterial replication (17, 18). The host encodes natural 
resistance- associated macrophage protein 1 (NRAMP1), which transports 
iron and manganese out of the phagosomal compartment. Though 
controversial, mutations in NRAMP1 have been demonstrated to confer 
resistance to tuberculosis in mice and humans (19-22). 
In contrast, although transition metals are critical to cellular life, in 
abundance they are toxic. Copper accumulates within Mtb- associated 
pulmonary lesions. This is thought to be a strategy by which the immune 
system restricts mycobacterial growth in vivo (23)9. This is further 
supported by the observation that, in comparison to other bacteria, Mtb is 
particularly susceptible to copper in vitro. Moreover, Mtb lacking the 
copper transporter MctB accumulated 100 fold more intracellular copper 
in vitro and was markedly attenuated within guinea pigs (23). In addition, 
INFγ mediated transportation of copper into the phagolysosomes of 
activated macrophages was lethal to resident intracellular bacteria (24). 
This lethality of copper is attributed to the fact that copper disables critical 
cellular enzymes by dislodging catalytic iron atoms. In addition, copper 
participates in Fenton chemistry, which results in the production of toxic 
hydroxyl radicals and may potentiate RNS mediated oxidative stress (25). 
Thus, the host capitalizes on the dual essentiality and toxicity of transition 
metals to eradicate invading pathogens (16).  
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The availability of molecular oxygen regulates mycobacterial growth.  
In the host, Mtb is thought to reside within oxygen-depleted tissue 
(26, 27). Individual macrophages, in which Mtb becomes sequestered, 
contain lower oxygen tensions than the extracellular space (28). These 
infected cells then aggregate forming avascular structures called 
granulomas within which oxygen tensions approach 1% (29-32).  
Although sudden exposure to anaerobiosis is lethal, Mtb can adapt to 
conditions in which oxygen is gradually depleted (33). In response to the 
gradual withdrawal of oxygen from the medium, Mtb carries out the 
orderly shut down of various cellular processes and enters into a 
nonreplicating persistent (NRP) state beginning once oxygen tensions 
reach 1%. NRP bacteria no longer divide or synthesize DNA and 
demonstrate limited RNA and protein synthesis (34). Furthermore, NRP 
Mtb are no longer sensitive to antibiotics that target these inactive cellular 
processes (27, 35).  
 
Oxygen regulates the growth of Mtb within the host. 
Before the advent of chemotherapy, surgical intervention to reduce 
Mtb’s access to oxygen was a leading treatment for TB. Intentional lung 
atelectasis allowed for near-complete pathologic and clinical resolution of 
disease (36). While this suggests that mycobacterial growth requires 
access to oxygen in vivo, evidence that oxygen regulates the growth of 
Mtb within infected humans is, necessarily, indirect.  
In order to investigate the in vivo oxygen dependence of Mtb, oxygen 
tensions were experimentally manipulated within the lung tissue of Mtb 
infected model organisms. Direct manipulation was achieved by 
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controlling the partial pressure of oxygen within inhaled air. Guinea pigs 
infected with Mtb and maintained in 10% oxygen contained reduced 
colony forming units (CFUs) within their lungs and spleens as compared 
to their Mtb-infected counterparts maintained under room air (21% 
oxygen) (37). Alternatively, indirect manipulation of oxygen by re-routing 
a percentage of the blood supply away from otherwise well-ventilated 
alveoli created an artificially elevated partial pressure of oxygen within 
the associated alveolar sacs, as oxygen was no longer carried off into the 
circulation by hemoglobin. Monkeys that received a surgical intervention 
to re-route blood from lung tissue prior to infection with Mtb, for example 
by pulmonary artery ligation, developed increased mycobacterial numbers 
within the associated lung tissue (38). Thus these initial experiments 
supported the centrality of oxygen in regulating mycobacterial growth in 
vivo. Further supporting evidence arose from the observation that TB-
associated lesions tend to localize within lung tissue containing the 
greatest oxygen tension. 
The diagnosis of TB in humans is made in part by capturing 
radiographic images of the lungs. This led to the observation that in 
adults, pathologic lesions associated with chronic pulmonary TB are often 
localized within the lung apices (39). As a result of gravity, the apices 
receive less blood flow than more inferior lung tissue, and therefore 
contain greater oxygen tensions, 132 mmHg as compared to 89 mmHg in 
more inferior tissue (40, 41). In order to determine whether the higher 
oxygen tensions of the lung apices contributed to the localization of TB-
associated pathology, Medlar and Sasano infected rabbits with Mtb and 
maintained a subset of infected animals in a vertical position to simulate 
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the erect posture of humans. Typically, Mtb infected (horizontal) rabbits 
develop tissue pathology in the posterior dorsal basal lung segments that 
contain the highest oxygen tensions. However, vertically oriented rabbits 
developed Mtb-associated lesions in the lung apices (42). While the 
results of this seminal experiment supported a relationship between 
oxygen tension and progressive TB lung pathology, an alternative 
explanation posited that impaired lymphatic clearance of antigens within 
the lung apices could account for these observations (40).  
Although these historic experiments suggested an association 
between oxygen and mycobacterial growth in vivo, it is not possible to 
conclude from them that Mtb infected hosts are hypoxic, or that oxygen 
regulates the growth of Mtb in the host. In the modern era, however, 
investigators have developed tools to directly address whether Mtb 
infected host tissues are hypoxic. Molecular markers of hypoxia, such as 
the nitroimidazoles, mycobacterial hypoxic response gene expression 
analysis and direct measurement of tissue oxygen tensions with an oxygen 
probe have been used to demonstrate that Mtb infected model hosts, such 
as the guinea pig, rabbit, macaque develop hypoxic tissue pathology (30). 
These same techniques have also indicated that the C3HeB/FeJ mouse 
model, but not BALB/c (43) or C57BL/6 (31, 32) mouse strains, develop 
hypoxic TB-associated lesions. Therefore, within model hosts that have 
demonstrated hypoxic, TB-associated tissue pathology, Mtb likely 
experiences hypoxia. That the availability of oxygen regulates 
mycobacterial growth in vitro is clear. Mycobacteria no longer replicate 
once oxygen tensions fall to, or below 1% (26, 27). Thus oxygen likely 
regulates mycobacterial replication in vivo as well.  
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When oxygen is scarce, Mtb respires the alternative electron acceptor 
nitrate. 
In response to hypoxia, Mtb induces the expression of the 
nitrate/proton symporter narK2, which allows for the rapid entry of nitrate 
into the cell (44). Nitrate is subsequently reduced to nitrite by the 
constitutively active nitrate reductase encoded by narGHJI (45). This 
process reportedly supports hypoxic ATP synthesis and redox balancing 
(46, 47). Moreover, the upregulation of this alternative respiratory 
pathway enhances the survival of Mtb challenged with sudden 
anaerobiosis (48). Human tissues contain abundant quantities of nitrate, 
which arise primarily from the diet and nitric oxide synthase (NOS) 
enzymes. NOS enzymes produce nitric oxide that auto-oxidize to form 
both nitrate and nitrite (49). Over the course of infection with Mtb, 
patients accumulate increasing concentrations of plasma nitrite (50, 51). 
This likely arises from the two NOS isoforms, endothelial and inducible 
(eNOS and iNOS respectively) that are expressed in the granulomatous 
tissue of TB patients (52-54). Mycobacterial nitrate reduction, which is 
responsible for the production of 2.5 mM nitrite by axenic cultures of Mtb 
(55), may also contribute to this pool of plasma nitrite.  
 
Mtb respires nitrate within primary human macrophages. 
Our laboratory recently adopted an alternative protocol to 
differentiate primary human macrophages. There are several features that 
distinguish this protocol from others (56). In particular, monocytes are 
differentiated in 10% oxygen in the gas phase over 2 weeks in a medium 
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containing 40% human plasma, 60% RPMI and the cytokines GMCSF 
and TNFα. The resultant macrophages better restricted the replication of 
Mtb over a period of weeks (57), as compared to macrophages 
differentiated using more traditional protocols, which are incubated under 
room air oxygen tensions of a period of days, in a medium composed of 
DMEM, 10% fetal bovine serum and MCSF (56). Initial experiments 
revealed that, despite culture under non-hypoxic oxygen tensions, 
macrophage-resident Mtb produced significant amounts of nitrite. This 
was immediately of interest as nitrate and nitrite can be reduced to form 
nitric oxide in vivo (49). 
 The nitrate-nitrite-nitric oxide pathway begins with the reduction of 
nitrate to nitrite by oral commensal bacteria, which can then be further 
reduced to nitric oxide through an array of physiologic processes, many of 
which are non-enzymatic (49). The reduction of nitrate or nitrite to form 
nitric oxide has been shown to reduce blood pressure (58, 59), enhance 
the efficacy of mitochondrial oxidative phosphorylation (60), impair 
platelet aggregation (61), and to exert carcinogenic (62) and antimicrobial 
effects (49, 63, 64). These broad effects arise once nitrate or nitrite is 
reduced to nitric oxide. However, nitrite has also been proposed to 
directly react with hemes and thiols without the intermediary formation of 
nitric oxide (65). 
 
Conclusions 
In the context of tuberculosis, nitrite is generally overlooked as 
simply a degradation product of NOS enzymes. This is in part due to the 
fact that nitrate is not a component of the standard cell medium used to 
  9 
culture Mtb axenically. In addition, in contrast to our protocol, traditional 
monocyte differentiation techniques typically involve the use of medium 
containing low levels of nitrate and so mycobacterial nitrate reduction is 
rarely appreciated in either axenic or co-culture experiments. 
 Although high concentrations of nitrite restrict the growth of Mtb 
without any associated lethality (55), this has remained mechanistically 
unexplained. Therefore we hypothesized that Mtb-derived nitrite might 
impact Mtb itself. Taken together, two central areas of investigation 
emerged from our observation that Mtb produced abundant amounts of 
nitrite within infected macrophages: first, what had prompted 
mycobacterial nitrate respiration, were macrophage-resident Mtb 
functionally hypoxic? Second, given the broad impact of the nitrate and 
nitrite on human physiology and the observation that nitrite impairs 
mycobacterial replication, we proposed to characterize additional 
consequences of Mtb-derived nitrite on the pathogen itself and to 
determine to what extent these effects resemble the well-documented 
effects of nitric oxide. 
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CHAPTER 2 
MYCOBACTERIUM TUBERCULOSIS GENERATES NITRITE IN HUMAN 
MACROPHAGES AT PHYSIOLOGIC OXYGEN TENSIONS: IMPACT ON 
MYCOBACTERIAL ATP CONSUMPTION AND GENE EXPRESSION∗ 
 
Summary 
In high enough concentrations, such as produced by inducible nitric oxide 
synthase (iNOS), reactive nitrogen species (RNS) can kill Mycobacterium 
tuberculosis (Mtb). Lesional macrophages in macaques and humans with 
tuberculosis (TB) express iNOS, and mice need iNOS to avoid 
succumbing rapidly to TB. However, Mtb’s own ability to produce RNS 
is rarely considered, perhaps because nitrate reduction to nitrite is only 
prominent in axenic Mtb cultures at oxygen tensions ≤ 1%. Here we 
found that cultures of Mtb-infected human macrophages cultured at 
physiologic oxygen tensions produced copious nitrite. Surprisingly, the 
nitrite arose from the Mtb, not the macrophages. Mtb responded to nitrite 
by ceasing growth; elevating levels of ATP through reduced consumption; 
and altering the expression of 120 genes associated with adaptation to 
acid, hypoxia, nitric oxide, oxidative stress, and iron deprivation. The 
transcriptomic effect of endogenous nitrite was distinct from that of nitric 
oxide. Thus, whether or not Mtb is hypoxic, the host expresses iNOS, or 
hypoxia impairs the action of iNOS, Mtb in vivo is likely to encounter 
RNS by producing nitrite. Endogenous nitrite may slow Mtb’s growth and 
prepare it to resist host stresses while the pathogen waits for 
                                                
∗ Amy Cunningham-Bussel, Tuo Zhang, and Carl Nathan, “Mycobacterium Tuberculosis Generates 
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immunopathology to promote its transmission.  
 
Introduction 
The ability to produce RNS is widely distributed among animals, 
plants and eubacteria. The high-output pathway of RNS production by 
host iNOS contributes to control of diverse infections (1, 2), including 
tuberculosis (TB) (3, 4), via impacts on both the pathogen and the host 
(5). Macrophages in the lungs of humans (3, 6, 7) and macaques (8) with 
TB express functional iNOS. Correlative evidence suggests that the action 
of iNOS may contribute to human control of TB (1, 2, 9, 10).  
Contributions of bacterial RNS production to host-pathogen 
interactions have only recently come under study. Bacterial NO synthases 
or nitrate reductases are sources of RNS that can contribute to antibiotic 
resistance (3, 4, 11, 12) and increase virulence (5, 13). Some commensal 
bacteria exploit host iNOS during colonic inflammation by using iNOS-
derived nitrate (NO3-) as a terminal electron acceptor (3, 6, 7, 14). Nitrate, 
along with nitrite (NO2-), is an auto-oxidation product of nitric oxide 
(.NO), the product of iNOS.  
In the host, Mtb is thought to survive over decades in hypoxic sites 
(8, 15, 16). When oxygen is scarce, Mtb reduces nitrate (NO3-) to nitrite 
(NO2-) as a means to maintain redox homeostasis and energy production 
(17). The mycobacterial respiratory nitrate reductase, encoded by 
narGHJI, is constitutively expressed (17), and functions at a low level 
under aerobic conditions when nitrate is taken up by passive diffusion 
(18). Hypoxia promotes the induction of narK2, a nitrate transporter and a 
member of the dormancy survival (DOS) regulon (17, 19-21), such that 
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Mtb cultured at ≤ 1% oxygen in the presence of nitrate rapidly produces 
nitrite up to a level of 2.5 mM (22). Further production is restricted in 
association with non-lethal cessation of bacterial growth (22). 
 Transcripts from narG, which encodes a subunit of the nitrate 
reductase, and narX, which lies downstream of narK2 and encodes a non-
functional nitrate reductase, were identified in granulomas from humans 
with TB (23, 24). This suggests that populations of mycobacteria residing 
within the human host are exposed to low oxygen tensions, and likely 
respire nitrate to adapt. Nitrate is a physiologic component of human body 
fluids, where it arises from the diet and from auto-oxidation of the NO 
produced not only by iNOS (NOS2) but also by the constitutively 
expressed enzymes NOS1 and NOS3. Studies in which nitrate was 
furnished in vitro revealed that Mtb’s ability to respire nitrate allows it to 
better withstand acid, nitrosative stress (25) or sudden anaerobiosis (26). 
The evolutionary success of “modern” Mtb strains, which are more 
prevalent than “ancestral” strains, has been attributed to their enhanced 
nitrate reductase activity (27). Although nitrate and nitrite reproduce the 
bioactivity of nitric oxide in vivo in a wide array of physiologic processes 
(28), reduction of nitrate to nitrite is rarely considered in studies of the 
host-pathogen relationship in TB. In fact, nitrate was omitted when the 
standard growth media were formulated in which almost all in vitro 
experiments with Mtb are currently conducted.   
During the course of modifying standard culture conditions for 
Mtb-infected human monocyte-derived macrophages (29), we observed 
abundant accumulation of nitrite in the supernatant.  Herein, we report the 
identification of Mtb as both the source of the nitrite and a highly 
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responsive target.  
 
Results 
Mtb respires nitrate in human macrophages cultured at non-hypoxic 
oxygen tensions.  
We differentiated normal donors’ monocytes into macrophages under 
10% oxygen for 2 weeks, activated them with interferon-g and infected 
them with Mtb, as described (29). Cultures of macrophages from multiple 
donors consistently accumulated nitrite in a time-dependent manner to a 
median level of 25 μM over 5 days (Figure 1a). This suggested that the 
macrophages may have expressed one of the three NOS isoforms. 
However, we detected no iNOS protein by immunoblot (Supplementary 
Figure S1, see Appendix 1) and no NOS1, NOS2 or NOS3 transcripts by 
microarray or RNA Seq (not shown). To see if Mtb might be the source, 
we infected macrophages with a strain of Mtb lacking narG. The mutant 
strain grows normally in aerobic culture and is as virulent as wild type 
Mtb in mice (15), but cannot respire nitrate. Macrophage cultures infected 
with ΔnarG Mtb accumulated no nitrite, while infection with a mutant 
strain complemented with the wild type narG allele led to accumulation 
of as much nitrite as infection with wild type (WT) Mtb (Figure 1B). 
Accumulation of nitrite was nearly abolished when the cultures were 
washed gently to replace most of the standard culture medium with 
medium containing negligible nitrate, and was restored when the nitrate-
deficient cultures were repleted with 5 mM nitrate (Figure 1C). Even 
when we cultured infected macrophages in conventional, hyperoxic levels 
of oxygen (21%), we observed narG-dependent nitrite accumulation in 
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the supernatant (Figure 1D). To further confirm that the resultant nitrite 
was a mycobacterial, rather than a host product, we infected macrophages 
with Mtb in the presence of the bactericidal antibiotic, rifampicin. 
Addition of rifampicin to macrophages 2 days prior to infection 
completely abolished nitrite production after infection. Treatment with 
rifampicin even 24 or 48 hours post infection markedly reduced the 
production of nitrite (Figure 1E).     
We wondered what levels of Mtb-derived nitrite might be attained in 
tissue sites such as granulomas, where the number of macrophages per 
unit volume vastly exceeds the non-physiologic ratio attainable in 
monolayer culture. To better simulate the cell densities of tissues, we 
cultured macrophages on Cytodex microcarrier beads. The narG-
dependent accumulation of nitrite in bead cultures reached 800 μM 
(Figure 1F). In both monolayer and bead culture, the colony-forming units 
(CFU) of Mtb recovered from the cultures were not significantly different 
for narG-deficient and WT Mtb (Cunningham-Bussel, 
MicrobiologyOpen, in press). 
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Figure 1. Nitrite generation by Mtb within primary human 
macrophages cultured in non-hypoxic levels of oxygen. (A) 
Accumulation of nitrite in supernatant of macrophages in monolayer 
culture in 10% oxygen infected with wild type (Wt) Mtb (MOI:5; 5x105 
bacteria) for the indicated times. Box and whisker plots depict median and 
5th-95th percentiles of results from 6 donors. (B) As in (A), but 
macrophages were uninfected or infected with narG-deficient Mtb (NarG) 
or Wt or complemented (NarGc) strains. Results for uninfected 
macrophages and those infected with NarG Mtb overlap near zero. Means 
± SD from one experiment representative of > 10. (C) Lack of 
accumulation of nitrite in nitrate-depleted medium. Macrophages were 
infected in the presence (*) or absence of 5 mM nitrate. Means ± SD for 
one experiment representative of 2. (D) As in (B), but with macrophages 
maintained under either 21% or 10% oxygen. Means ± SD for one 
experiment representative of 2. (E) Impact of rifampicin (RIF) on nitrite 
production. Where indicated, macrophages were infected with Wt Mtb 
(MOI: 5) for 3 days in 10% oxygen in the presence or absence of 
rifampicin (1 μg mL-1). Rifampicin was added 2 days before, 24 hrs after 
or 48 hrs after infection. Uninfected macrophages were treated with 
rifampicin for the duration of the experiment. Nitrite was measured on 
day 3 after infection. Means ± SD, n= 2 experiments. (F) As in (B) but 
using ~20-fold higher numbers of macrophages grown on Cytodex 
surface microcarrier beads in 10% oxygen and then infected with Mtb 
(MOI: 5; 107 bacteria). Means ± SD, n= 2 experiments.   
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Figure 1 (continued) 
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Oxygen tension within Mtb-infected human macrophages functionally 
approximates 1%.  
Abundant mycobacterial nitrate reduction within infected 
macrophages incubated under ambient oxygen tensions of 10% and 21% 
suggested that Mtb experienced an intracellular oxygen tension that 
approximated 1%. To test this, we compared the expression of DOS 
regulon members hspX and fdxA by Mtb cultured axenically or within 
infected macrophages. As reported (20), we found that Mtb cultured 
axenically in standard medium under 1% oxygen but not 21% oxygen 
induced both genes by ~100-fold (Figure 2A). Mtb residing within 
macrophages also highly induced the two DOS genes, particularly under 
10% oxygen (Figure 2B) and less so under 21% oxygen (Figure 2C). To 
confirm this surprising finding, we treated Mtb-infected macrophages 
with pimonidazole. At oxygen tensions ≤ 1% pimonidazole, is reduced to 
a form that covalently modifies proteins, as detected by 
immunocytochemistry (30). Macrophages cultured at an oxygen tension 
of 10% showed intense pimonidazole staining, whether or not they were 
Mtb-infected (Figure 2D). Even under hyperoxic conditions (21% 
oxygen), considerable pimonidazole staining was detected (Figure 2D). 
Thus, despite incubation under ambient tensions of 10% or even 21%, 
intracellular oxygen tensions in the human macrophages functionally 
approximated 1%.  
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Figure 2. Functional evidence for intracellular hypoxia in primary 
human macrophages cultured at physiologic tissue-level (10%) or 
hyperoxic (room air) oxygen tensions. (A) Expression of DOS regulon 
genes hspX and fdxA in axenic cultures of Wt or narG-deficient (NarG) 
Mtb in 21% or 1% oxygen in standard medium without nitrate, OD580 0.1 
(means ± SD, n=2 experiments). (B, C) Expression of hspX and fdxA by 
Wt or NarG strains within human macrophages incubated in 21% or 10% 
oxygen for 10 hours (MOI: 40). Means ± SD, n=2 experiments. (D) 
Pimonidazole staining of macrophages infected or not with Wt Mtb 
(MOI: 5) and incubated at the oxygen tensions indicated. 
Photomicrographs: Representative images. Blue: DAPI- stained nuclei, 
Red: pimonidazole adducts. Graph: Quantification of pimonidazole 
staining intensity. 0 PIMO, uninfected cells treated with neither 
pimonidazole nor DMSO. DMSO, uninfected cells treated with only the 
vehicle. Each dot represents the average intensity in ~500 macrophages. 
Horizontal lines indicate the means of 2 independent experiments. 
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Endogenously generated nitrite represses mycobacterial growth and ATP 
consumption.  
As noted by Wayne and Hayes (22), nitrite, whether endogenously 
produced or exogenously supplied, suppressed the growth of Mtb under 
21% oxygen (Figure 3A). The concentration-dependence of this effect 
was similar for WT, narG-deficient and complemented Mtb (Figure 3A). 
In contrast, when we incubated the 3 strains in 1% oxygen for 3 days with 
5 mM nitrate, followed by return to 21% oxygen, only the WT and 
complemented strains failed to resume growing, reflecting that they 
generated endogenous nitrite from nitrate, which narG-deficient Mtb 
could not (Figure 3B). The failure of cultures of WT Mtb to increase in 
turbidity after generating nitrite reflected bacteriostasis, not cell death, 
because the number of CFU recovered was unaffected (Figure 3C).  
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Figure 3. Nitrite represses mycobacterial growth. (A, B) Strains of Mtb 
designated as in Figure 1 (OD580 0.1, as marked by horizontal dotted lines) 
were incubated in the presence of the indicated concentrations of nitrite 
(A) or nitrate (B) for 3 days in 1% oxygen and then transferred to 21% 
oxygen for 5 days before growth was assessed by measuring OD580. 
Means ± SD, n=2 experiments. (C) As in (A) and (B), except that CFU 
were determined at the end of the 3-day incubation in 1% oxygen for wild 
type Mtb. Means ± SD, n=2 experiments. 
 
It is not known how nitrite impairs aerobic mycobacterial growth. 
We suspected an impact of nitrate respiration on intrabacterial ATP, 
because nitrite has been shown to inhibit bacterial respiration and prevent 
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complemented strains of Mtb axenically for 3 days under 1% oxygen 
either at high density (OD: 0.1, ~ 5 x 107 cells mL-1) or low density (OD: 
0.01, ~ 5 x 106 cells mL-1) in the presence of 5 mM nitrate and measured 
ATP in their lysates. As expected, in the low-density cultures the 
concentration of nitrite remained low. Under these conditions, ATP levels 
in WT and narG-deficient Mtb were not significantly different (Figure 
4A). In contrast, high-density cultures of the WT and complemented 
strains contained significantly more ATP than the narG-deficient strain, 
confirming an observation of Tan et al. (25) (Figure 4A).  
Tan et al. (25) attributed this result to increased ATP production by 
Mtb using nitrate as an electron acceptor when oxygen was limiting. 
However, when we added 2.5 mM exogenous nitrite to low-density 
cultures of Mtb in 1% oxygen, ATP levels were increased even farther 
than seen with WT Mtb given twice as much nitrate (Figure 4B). The 
ATP-elevating effect of exogenous nitrite was not dependent on the 
presence of narG or nirBD, which encodes a nitrite reductase (32). Thus, 
it appeared that nitrite, a product of nitrate respiration, led to 
accumulation of ATP in Mtb in a manner that did not depend on Mtb’s 
donation of electrons to nitrate.  
To test if nitrite itself was responsible for this effect, as opposed to 
nitric oxide, to which nitrite can be converted, we incubated low-density 
Mtb cultures with 5 mM nitrate as a control or with diethylenetriamine-
NO adduct (DETANO), a compound that decomposes to release nitric 
oxide with a half-life of ~22 hours at pH 7.4. DETANO also elevated 
intrabacterial ATP levels in WT, narG-deficient and the complemented 
strains. Both nitrite and DETANO increased intrabacterial ATP in a 
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concentration-dependent manner. DETANO was ~25-fold more potent 
than nitrite (Figure 4C, D). Thus, either nitrite or nitric oxide potentially 
arising from it appeared to increase ATP.  
We next considered whether nitrite or its possible conversion 
products might increase ATP production or decrease ATP consumption. 
Nitrite repressed the growth of Mtb; therefore, we considered it unlikely 
that nitrite enhanced the synthesis of ATP. Thus, we compared the 
consumption of exogenous ATP in lysates from nitrite-treated and 
untreated Mtb, after first demonstrating that neither nitrite nor nitric oxide 
interfered with the ATP assay (not shown). WT Mtb was incubated with 
or without nitrite as described above for 3 days in 1% oxygen. Whole cell 
lysates were prepared on ice, moved to room temperature and allowed to 
consume endogenous ATP until it was no longer detectable, which 
required less than 20 minutes. We then added various amounts of 
exogenous ATP to the lysates and immediately measured its 
concentration. We consistently recovered greater amounts of exogenous 
ATP in lysates from nitrite-treated Mtb than untreated Mtb (Figure 4E). 
Time-course measurements of the disappearance of exogenous ATP 
(Supplementary Figure S2, see Appendix 1) supported the interpretation 
that consumption of ATP was slower in lysates from nitrite-treated Mtb 
than from untreated Mtb.  
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Figure 4. Endogenously generated or exogenously supplied nitrite 
elevates ATP in Mtb and suppresses ATP consumption in its lysates. 
(A) Intrabacterial ATP content measured in wild type (Wt), narG-
deficient (NarG) or complemented (NarGc) strains of Mtb incubated at 
high (0.1) or low OD580 (0.01) for 3 days in 1% oxygen in the presence of 
5 mM nitrate. Results are expressed per mg protein in the lysate and are 
means ± SEM from 2 experiments.) (B) Impact of exogenous nitrite or 
nitrate on ATP content in Wt, narG-deficient (NarG), nirB-deficient 
(NirB) and respective complemented strains (NarGc, NirBc) of Mtb 
incubated for 3 days in 1% oxygen. (Means ± SEM, n=3 experiments). 
(C) As in (B), but comparing the impact of single concentrations of nitrate 
(5 mM) and DETANO (200 μM). Means ± SEM, n=3 experiments. (D) 
As in (C), but comparing the impact of varied concentrations of nitrate (y-
axis on the right) and DETANO (y-axis on the left). Means ± SEM, n=2 
experiments. (E) Recovery of exogenous ATP added to lysates from Wt 
Mtb that had been incubated in the presence or absence of 2.5 mM nitrite 
for 3 days at 1% oxygen. ATP was added only after cell lysates had 
consumed endogenous ATP. Means ± SEM, n=2 experiments. P values 
were determined by unpaired t tests. 
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Figure 4 (continued) 
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Endogenously generated nitrite regulates the Mtb transcriptome.  
Having demonstrated an effect of nitrite on ATP metabolism, we 
characterized the impact of endogenously generated nitrite more broadly 
by examining its effect on Mtb gene expression as assessed by RNA Seq. 
Samples of Mtb were prepared following the same protocol that revealed 
that mycobacterial nitrate respiration repressed subsequent bacterial 
growth in air (Figure 3a-b).  In 3 independent experiments, we treated 
axenic cultures of Mtb with or without 5 mM nitrate for 3 days at 1% 
oxygen to allow for the generation of endogenous nitrite and then 
transferred the cultures to 21% oxygen overnight. Figure 5 refers to these 
samples as ”untreated” and “nitrate”, respectively. Two further control 
cultures were prepared as above, except that one was treated with 2.5 mM 
nitrite in place of nitrate and the other was exposed neither to nitrate nor 
nitrite but its RNA was collected at the conclusion of the 3 day incubation 
in 1% oxygen, without an ~18 hour culture in 21% oxygen. Figure 5 
refers to these two samples as ”nitrite” and “untreated 1% oxygen,” 
respectively. Ribosomal RNA was removed from the total RNA by 
oligonucleotide-based hybridization. Sequences determined in three 
separate sequencing runs were aligned to the Mtb H37Rv genome 
(Accession NC_000962.3). After culling sequences encoding ribosomal 
RNA, ~3x106 reads per sample were mapped to coding regions, covering 
~99.9% of the coding genome. Gene expression was reported as reads per 
kilobase per million mapped reads (RPKM).  
We found that 120 genes were significantly regulated by provision 
of nitrate. Those induced are listed in Supplementary Table S1 and those 
repressed are listed in Supplementary Table S2, see Appendix 1. 
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Inspection of the list suggested that the most informative comparisons 
would be with reports of Mtb’s transcriptional adaptation to host-imposed 
stresses (33), such as hypoxia (20), iron restriction (34), acid (pH 5.5) 
(35), hydrogen peroxide (10 mM) (36), nitric oxide (50 mm) (21), and 
residence in mouse macrophages (35, 37) 
We first analyzed expression of the DOS regulon, which is induced 
by three of these conditions—hypoxia (20), nitric oxide (21), and 
residence in macrophages (35, 37). The average expression of all 47 DOS 
regulon genes was nearly the same for the “untreated” and “untreated 1% 
oxygen” samples (Figure 5A, first two columns). The close 
correspondence of DOS induction in these two conditions was also 
evident for each DOS gene considered individually (Figure 5B).  
Surprisingly, in comparison to the untreated sample, the average 
expression of the DOS regulon was significantly repressed by provision of 
nitrate (p< 0.0004) (Figure 5A). Individually, 27 DOS genes were 
significantly repressed in nitrate-treated Mtb (Figure 5C). (To achieve 
statistical significance for all 47 DOS genes considered individually, we 
would likely need to sequence more samples.) This effect of nitrate could 
be attributed to generation of nitrite, because the effect was qualitatively 
and quantitatively the same when nitrite itself was provided (Figure 5D). 
Finally, the effect of nitrite could not be ascribed to conversion to nitric 
oxide, in that nitric oxide has the opposite effect: it induces the DOS 
regulon, rather than repressing it. This is shown in Figure 5E, which plots 
the present results for 28 DOS genes: 27 that were significantly repressed 
by nitrite and reported to be induced by hypoxia (20) and 28 that were 
significantly repressed by nitrite and reported to be induced by 50 mM 
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nitric oxide (21). Hypoxic cultures of Mtb have been reported to 
accumulate up to 2.5 mM nitrite and no more (22). These results offer an 
explanation: nitrite negatively regulates its own accumulation by limiting 
the expression of the DOS regulon and thus narK2 (Supplementary Figure 
3, see Appendix 1).  
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Figure 5. Respiration of nitrate represses expression of the DOS 
regulon in Mtb. (A-D) RPKM for DOS genes as determined by RNA Seq 
for Wt Mtb incubated in 1% oxygen for 3 days (“untreated 1% oxygen”) 
or incubated in 1% oxygen for 3 days in the absence (“untreated”) or 
presence of 5 mM nitrate (“nitrate”) or 2.5 mM nitrite (“nitrite”), as 
indicated and transferred to 21% oxygen overnight. (A) The average 
expression of all 47 DOS genes across all samples (means ± SD) for the 
“untreated” and “nitrate” samples in 3 independent samples per condition, 
for the “untreated 1% oxygen ” and “nitrite” samples (n=1 experiment per 
condition; see Methods). The p value was determined by an unpaired t 
test. (B) Gene-by-gene comparison of expression in the “untreated 1% 
oxygen” sample and the “untreated” sample. (C) Expression of the DOS 
genes that were significantly regulated by nitrate respiration compared to 
expression of each such gene in the untreated sample. (D) Expression of 
each DOS gene from Wt type Mtb treated with 5 mM nitrate as compared 
to a sample treated with 2.5 mM nitrite. (B-D) Red lines indicate 1:1 
correlation; dashed lines indicate a 20% deviation from a 1:1 correlation. 
(E) Comparison of the expression of individual genes significantly 
regulated by nitrate in these experiments, with their reported regulation in 
hypoxia (20) or upon exposure to DETANO as a source of nitric oxide 
(21). The x-axis indicates the regulation of shared genes by the condition 
of interest and the y-axis indicates their regulation by nitrate respiration. 
All y values above or below the grey bar were regulated greater than 2-
fold. 
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Figure 5 (continued) 
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Of the 120 genes that were significantly regulated by nitrate 
respiration, many overlapped with genes that were regulated by Mtb 
residing within activated mouse macrophages (35, 37) (Figure 6AB). In 
addition, Schnappinger et al. reported a subset of genes that were 
specifically regulated by iNOS. However, there was no correlation 
between regulation of genes by Mtb’s respiration of nitrate and those 
regulated specifically by Mtb’s residence in macrophages that expressed 
iNOS (37) (Figure 6A). This provided further evidence that the effect of 
endogenously generated nitrite was not solely mediated by conversion to 
nitric oxide.  
Many Mtb genes regulated by nitrate respiration were reported to 
be similarly regulated in Mtb exposed to iron restriction (34) (Figure 6C), 
pH 5.5 (35) (Figure 6D), or treatment with 10 mM hydrogen peroxide 
(36) (Figure 6E). Table 1 presents the total number of genes regulated by 
nitrate respiration and reported to be regulated by these and other 
physiologic stimuli. After standardization to account for gene lists of 
differing size, the comparison indicates the number of genes expected to 
overlap by chance and whether the overlap is statistically significant. This 
analysis suggested that nitrate regulates the expression of genes that are 
also regulated when Mtb is exposed to several host-imposed stresses.  
  38 
 
Figure 6. Comparison of the impact of nitrate respiration on the Mtb 
transcriptome with the impact of (A, B) residence within 
macrophages,  (C) iron restriction, (D) exposure to pH 5.5, or (E) 
treatment with 10 mM hydrogen peroxide. Results of the present 
experiments and literature reports are graphed as in Figure 5E.  The 
literature results were from the following studies. (A) (37).  (B) (56). (C) 
(34) (D) (56). (E) reported by (36).  
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Table 1. Comparison of regulation of expression of Mtb genes by 
nitrate respiration observed here and by physiologic situations or 
stresses as reported in the literature. The total number of genes induced 
or repressed by nitrate respiration is listed along with the total number 
reported to be regulated by the indicated condition. The number regulated 
in common is compared to the number that would be expected to show a 
similar regulation by chance calculated by a Fisher’s exact test. The 
columns labeled “number induced/repressed by nitrate respiration” refer 
only to the number of overlapping genes. “Percent of total gene list that 
overlaps” indicates the percent of all genes regulated by nitrate respiration 
that are also regulated by the condition of interest. The associated 
significance of this overlap, listed as a p value in the final column, was 
calculated using a Fisher’s exact test. Of note, genes regulated by 
mitomycin C-induced DNA damage and starvation did not significantly 
overlap with genes regulated by nitrate respiration. 
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Table 1 (continued)
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Discussion 
Within the host, both host NOSs and mycobacterial nitrate 
reductase can serve as sources of nitrite. However, while mycobacterial 
nitrate reduction is markedly induced by hypoxia (17), NOSs require 
oxygen as a substrate (38), and at oxygen tensions of 1%, iNOS loses 80-
90% of its activity (39). Therefore, the activities of host iNOS and 
mycobacterial nitrate reductase could be spatially and temporally 
segregated, depending on their access to molecular oxygen. 
The studies reported here led to four inter-related findings. First, 
there can be a striking dissociation between the oxygen tension in culture 
and the functional oxygen concentration in macrophage phagosomes. 
Although a dissociation was previously noted between oxygen 
concentration in extracellular fluid and in mouse macrophage phagosomes 
(40), to our knowledge this is the first report that the level of oxygen in 
the phagosomes of primary human macrophages cultured at physiologic 
tissue oxygen levels of 10% or even 21% approximates 1%  functionally, 
as reflected by Mtb’s induction of DOS genes and copious reduction of 
nitrate. The low functional level of intramacrophage oxygen was not 
dependent on ingestion of Mtb. In agreement with James et al. (29, 40), 
we speculate that the steep gradient between atmospheric and intracellular 
oxygen reflects a rate of mitochondrial oxygen consumption that outpaces 
diffusion from the gas phase through the extracellular fluid and across the 
plasma membrane. If Mtb likewise experiences functional hypoxia within 
human macrophages at physiologic oxygen tensions in vivo, then Mtb’s 
respiration of nitrate to nitrite is likely to be much more widespread than 
previously appreciated, and the convention of culturing Mtb in room air 
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levels of oxygen in the absence of nitrate is likely to be misleading with 
regard to Mtb’s physiology.  
Second, nitrite, whether endogenously produced or exogenously 
supplied, affects Mtb profoundly, although we may have only scratched 
the surface in characterizing its effects. Besides halting Mtb’s growth, 
impairing its consumption of ATP and altering its transcriptome, 
mycobacterial nitrite also markedly reduces Mtb’s susceptibility to 
isoniazid (Cunningham-Bussel, MicrobiologyOpen, in press). We do not 
know the major ATP-consuming pathway(s) in Mtb that function(s) in 
whole cell lysates and that nitrite inhibits. This contrasts with the reported 
effect of nitrite to reduce the amount of intrabacterial ATP in P. 
aeruginosa (31, 41). 
Third, the effects of nitrite and nitric oxide partially overlap but in 
some respects are diametrically opposed. The effect of nitrite is also 
distinct from the effect of the respiration of nitrate, from which the nitrite 
arises. The ability of nitrite to affect biologic systems in its own right, 
rather than through conversion to more reactive forms, has been proposed 
(42, 43), and is supported by these results. For example, nitrite can 
oxidize ferrous iron to the ferric state and displace iron from iron-sulfur 
clusters (44, 45). The induced expression of mycobactin synthase genes 
suggests that Mtb-derived nitrite inactivated iron-containing enzymes, 
rendering the Mtb functionally iron-deficient despite the high iron content 
of the medium.  DOS regulon expression is coordinated by the heme-
containing kinases DosS and DosT, which function as redox and hypoxia 
sensors, respectively. Hypoxia, carbon monoxide and nitric oxide are 
physiologic ligands that induce DOS regulon expression by modulating 
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the oxidation and ligation states of the iron atoms in DosS and DosT (46). 
Nitrite may repress DOS regulon expression by oxidizing the iron of these 
sensor kinases in a manner that prevents their regulation by other 
physiologic ligands. Oxidation of iron in additional enzymes, such as 
ribonucleotide reductase, may also contribute to the ability of nitrite to 
slow or halt Mtb’s growth (47-49).  
	
Last, the shared regulation of genes by nitrate and by the 
potentially mycobactericidal conditions of iron restriction and exposure to 
acid and hydrogen peroxide suggests that nitrate respiration may benefit 
Mtb in vivo by preparing it to withstand the latter stresses. Nitrite is highly 
diffusible, as evidenced by its accumulation in the plasma of Mtb-infected 
individuals (50-52). Endogenously produced nitrite may diffuse within 
infected tissue and contribute to a pre-emptive induction of Mtb genes 
that benefit Mtb’s survival in a hostile host environment.   
To date, in vivo experiments to investigate the consequence of 
mycobacterial nitrate respiration have been limited to the mouse, where 
“granulomas” are areas of pneumonitic consolidation lacking the layered, 
fibrous-capped structure found in the granulomas of humans and non-
human primates with TB. Mtb-infected granulomatous tissue in the mouse 
had a measured oxygen tension averaging ~40 mm Hg (or 2-9% oxygen) 
(15, 53) and did not stain with a hypoxia-sensitive 2-nitroimidazole probe 
(20, 54). Furthermore, Mtb in mice did not express the only DOS regulon 
member tested, narK2, until the onset of the adaptive immune response 
almost three weeks after infection, such that DOS regulon expression may 
have depended upon the activation of iNOS (55) rather than hypoxia. 
When mouse macrophages cultured in 21% oxygen were infected with 
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Mtb in vitro, DOS regulon induction depended on expression of iNOS 
(21, 37). In contrast, in the present studies, exposure of human 
macrophages to Mtb over an interval long enough to allow for 
phagocytosis but too brief to allow for nitrite accumulation led to marked 
induction of the DOS regulon in the absence of any NOS. Therefore, to 
the extent that DOS regulon induction is an indicator of hypoxia, human 
macrophages as cultured here appear to achieve a greater degree of 
functional intracellular hypoxia in vitro than mouse macrophages as 
usually cultured. The same may be true in vivo, insofar as iNOS expressed 
in mouse macrophages during Mtb infection appears to access sufficient 
oxygen to restrain Mtb growth (3, 37). Therefore, experiments with NarG-
deficient Mtb in the mouse may not reflect the functional relevance of 
mycobacterial nitrate respiration in the human host.  
 RNS can act as double-edged swords, depending on their level (56, 
57). The present results bring this truism into sharp relief with respect to 
Mtb. High levels of RNS can kill Mtb, but low levels may do the 
pathogen a service. First, nitrite of host or mycobacterial origin may 
induce genes with whose help Mtb can withstand other host stresses. 
Second, nitrite slows or stops Mtb’s aerobic replication. Mtb may thus 
avoid killing a host that has not yet destroyed enough lung tissue to 
provide Mtb with a path back to the air. Third, nitrite increases 
intrabacterial ATP. Once Mtb is expelled from the host within aerosolized 
droplets, this reserve of metabolic energy may facilitate colonization of 
new hosts. Drugs that inhibit Mtb’s defenses against RNS may therefore 
be useful even in settings where immunodeficiency impairs the expression 
of host iNOS or hypoxia limits its action.  
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Methods 
Isolation and differentiation of primary human monocytes  
Heparinized peripheral blood was collected by venepuncture from healthy 
human donors who provided informed consent under an IRB approved 
protocol. Monocytes were isolated and differentiated as described (29, 
34). Briefly, mononuclear cells isolated by centrifugation over Ficoll-
Paque (GE Healthcare) were subject to positive selection using magnetic 
beads coupled to anti-CD14 antibodies (Milteyi Biotec) and cultured in 
60% RPMI, supplemented with 1% glutamax, 40% human plasma and 
GM-CSF and TNFα (0.5 ng ml-1 each) at 5x105 cells ml-1. 30% of the total 
culture volume was replaced with fresh medium and cytokines twice a 
week. For Cytodex1 bead culture, Cytodex 1 beads were prepared 
according to the instructions provided by the manufacturer (GE 
Healthcare). The cells were plated at a density of 2x106 cells ml-1 per well 
of a 24 well plate and 50% of the medium was replaced three times a 
week. After 2 weeks at 10% or 21% O2 and 5% CO2 at 37°C in a 
humidified atmosphere, the cells were activated with IFNγ (5 ng ml-1) and 
infected with Mtb the following day. No antibiotics were used at any 
point. 
To remove most nitrate from the medium, 1 day prior to infection 
the cells were washed 3 times with PBS and the medium was replaced 
with DMEM with 10% human plasma, GM-CSF, 0.5 ng mL-1 TNFα and 
5 ng mL-1 IFNγ. 
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Measurement of nitrite  
Nitrite levels in the supernatants of macrophage cultures were measured 
by the Griess assay (41, 56) using nitrite standards prepared in the same 
medium used to culture the macrophages.  
 
Preparation of Mtb 
M. tuberculosis H37Rv was grown in Middlebrook 7H9 broth 
supplemented with 0.2% glycerol, 0.5% BSA, 0.2% dextrose and 0.085% 
NaCl (ADNaCl) with 0.05% Tween 80. The narG, nirB and 
complemented strains (36, 42) were generously provided by Dr. F. Bange. 
Single-cell suspensions were collected in the supernatant after 
centrifugation at 120 G for 10 minutes. For macrophage infection, ~2x107 
bacteria were pelleted by centrifugation and resuspended in PBS. CFUs 
were determined by serial dilution in 0.1% TritonX-100, and plating on 
Middlebrook 7H11 agar with 10% oleic acid-albumin-dextrose-catalase 
(OADC) enrichment (Difco, BD) supplemented with 0.5% glycerol for 2-
3 weeks at 37°C, 5% CO2. 
 
Pimonidazole staining  
Uninfected or Mtb-infected (MOI: 5) macrophages were treated with or 
without 200 μM pimonidazole for 24 hours, washed and stained anti-
pimonidazole antibody coupled to allophycocyanin (APC) (Hypoxyprobe 
RedAPC Kit) as recommended by the manufacturer and counterstained 
with the nuclear stain 4',6-diamidino-2-phenylindole (DAPI). APC and 
DAPI signals were quantified at the Cell Screening Core Facility, Weill 
Cornell Medical College and analyzed using MetaXpress High Content 
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Image Acquisition & Analysis Software (Molecular Devices). The APC 
signal was normalized to the number of nuclei per image.  
 
Intrabacterial ATP  
Single-cell suspensions of Mtb (7x108 per condition) were incubated in 
7H9/ADNaCl with 0.05% Tween 80 at an OD580 of 0.07 in 1% O2, 5% 
CO2 at 37 °C in a humidified atmosphere, pelleted by centrifugation, 
washed once in PBS, pelleted and processed immediately for ATP 
measurement or frozen at -80°C for later use. For a single endpoint 
measurement, the pellet was resuspended in 220 μl of standard lysis 
buffer: 100 mM Tris-OH and 1 mM PMSF, pH 7.4, with 1x protease 
inhibitor (Roche: cOmplete ULTRA Tablets, Mini, EDTA-free, EASY 
pack catalogue number: 05892791001) added immediately prior to 
bacterial lysis in a bead-beating homogenizer with silica beads for 2 
cycles with incubation on ice between them. After brief centrifugation to 
pellet silica beads, 1:1:2 (v/v/v) ratio of cell lysate (50 μL), lysis buffer 
and ATP reagent were added in triplicate to a black 96-well opaque plate 
for the BacTiter-Glo Microbial Cell Viability Assay (Promega). 
Luminescence was read immediately using a SpectraMax L 
Luminescence Microplate Reader (Molecular Devices). For rate 
measurements, the lysate was filter-sterilized (0.22 μm Corning Costar 
Spin-X Plastic Centrifuge Tube Filters at 10,000G for 20-30 minutes). 
ATP was measured in an aliquot and reagent ATP was added to the 
remaining lysate from which triplicate 10 μL aliquots were immediately 
dispensed to the assay plate. At the indicated times, 90 μL of lysis buffer 
and 100 μL of ATP reagent were added and luminescence measured. ATP 
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standards diluted in lysis buffer were prepared fresh for each experiment. 
The intrabacterial ATP for each sample was normalized to the protein 
concentration of each sample (Bio-Rad Protein Assay).  
 
Quantitative RT-PCR  
Macrophages (5x106 per T25 flask) were cultured in 10% or 21% oxygen 
and infected with Mtb (MOI: 40) for 10 hours. The monolayer was 
washed twice with PBS. Trizol (2 mL) was added to each flask and the 
cells detached and using a rubber scraper. Alternatively, ≥ 2x109 bacteria 
were incubated per condition in 1% or 21% oxygen for 3 days in standard 
medium, in the absence of nitrate. An equal volume of buffer containing 5 
M guanidinium thiocyanate, 25 mM sodium citrate, 20 mM N-lauryl-
sarcosine, 0.7% v/v β-mercaptoethanol was added. The bacteria were 
pelleted by centrifugation, 1 mL of Trizol added per sample and the 
suspension beaten with silica beads. RNA extraction was conducted using 
an RNeasy kit (Qiagen) in accordance with the manufacturer’s 
instructions, except that off-column DNAse digestion was performed for 
2 hrs at 37 °C. One mg of total RNA was reverse-transcribed using the 
GeneAmp RNA PCR Kit (Applied Biosystems). Quantitative RT-PCR 
was performed using gene specific primers (TaqMan Gene Expression 
Assay, Life Technologies) and the SuperScript III Platinum Two Step 
qRT-PCR Kit (Life Technologies) with a 7900HT Fast Real Time PCR 
System (Applied Biosystems). Each experiment was performed in 
triplicate. Values within the linear range of the primers were normalized 
to values for 16S rRNA.  
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RNA Sequencing  
At least 5x109 bacteria per sample were incubated in 1% oxygen and left 
untreated or treated with 5 mM nitrate or 2.5 mM nitrite. After 3 days 
RNA was collected from one flask of untreated Mtb. The remaining flasks 
(untreated or nitrate- or nitrite- treated) were transferred to 21% oxygen 
for an additional overnight incubation before RNA collection. RNA 
samples with an RNA Integrity Number (RIN) (Bioanalyzer (Agilent 
Technologies 2100) value > 8 were processed further. Ribosomal RNA 
was removed by hybridization with magnetic bead-coupled 
oligonucleotides (MicrobExpress Kit, Life Technologies). Libraries were 
prepared according to the manufacturer’s instructions and resultant RNA 
sequenced (HiSeq2000/1000, Illumina). Single-ended sequencing reads 
were aligned to the reference genome of Mtb H37Rv using the Burrows-
Wheeler Alignment tool (20, 50) (Accession NC_000962.3). Cufflinks 
(53) was used to measure transcript abundances in reads per kilobase of 
exon per million mapped reads (RPKM) as well as to find differentially 
expressed genes. Regulation was considered significant for changes with a 
p value corrected for multiple comparisons (pcorr) < 0.05 (Supplementary 
Tables 1 and 2, see Appendix 1). The samples labeled “nitrate” and 
“untreated,” were prepared in 3 independent experiments. Only one 
sample was available for the “nitrite” and “untreated 1% oxygen” 
conditions. These samples were only used to evaluate the expression all 
47 genes of the DOS regulon as a unit, with the expression of each gene 
serving as a control for the expression of the others.  
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Statistical analysis  
Statistical analysis was performed as indicated in the figure legends using 
Prism 5.0f for Macintosh (GraphPad Software, San Diego, CA). 
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CHAPTER 3 
 
NITRITE IMPACTS THE SURVIVAL OF MYCOBACTERIUM TUBERCULOSIS IN 
RESPONSE TO ISONIAZID AND HYDROGEN PEROXIDE * 
Summary 
When access to molecular oxygen is restricted, Mycobacterium 
tuberculosis (Mtb) can respire an alternative electron acceptor, nitrate. We 
found that Mtb within infected primary human macrophages in vitro at 
physiologic tissue oxygen tensions respired nitrate, generating copious 
nitrite. A strain of Mtb lacking a functioning nitrate reductase was more 
susceptible than wild type Mtb to treatment with isoniazid during 
infection of macrophages. Likewise, nitrate reductase-deficient Mtb was 
more susceptible to isoniazid than wild type Mtb in axenic culture, and 
more resistant to hydrogen peroxide. These phenotypes were reversed by 
the addition of exogenous nitrite. Further investigation suggested that 
nitrite might inhibit the bacterial catalase. To the extent that Mtb itself is 
the most relevant source of nitrite acting within Mtb, these findings 
suggest that inhibitors of Mtb’s nitrate transporter or nitrate reductase 
could enhance the efficacy of isoniazid.  
 
Introduction 
Nitrate (NO3-) and nitrite (NO2-) arise in the mammalian host from 
three major sources—dietary, bacterial and host. Dietary nitrate is 
absorbed into the blood. Some is reduced by oral and gastrointestinal 
                                                
* Amy Cunningham-Bussel, Franz-Christoph Bange, and Carl Nathan, “Nitrite Impacts the Survival of 
Mycobacterium Tuberculosis In Response to Isoniazid and Hydrogen Peroxide,” MicrobiologyOpen 
(Manuscript in press)  
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commensals, producing nitrite, which is also absorbed. Nitric oxide 
synthases (NOSs), including those that are constitutively expressed, 
produce nitric oxide, which autoxidizes to nitrate and nitrite. Even in 
healthy individuals, in whom relatively little of the high-output NOS 
isoform (iNOS) is expressed (1), nitrate is present in plasma at levels of 
20-40 µM (2). In patients with tuberculosis (TB), iNOS and other NOSs 
are expressed in granulomas (1, 3). 
At oxygen tensions of 1% or lower, Mtb itself can produce nitrite as 
it maintains ATP synthesis and redox homeostasis by reducing an 
alternative electron acceptor, nitrate. Mtb constitutively expresses the 
narGHJI operon, which encodes Mtb’s only functional nitrate reductase 
(4, 5). However, transport of nitrate into the bacterium depends on 
transcription of a nitrate transporter encoded by narK2, a member of the 
dormancy survival (DOS) regulon (6-8). The narK2 gene is expressed in 
axenically cultured Mtb only when oxygen levels fall below 1%. 
Induction of narK2 markedly enhances mycobacterial nitrate respiration 
(4). RNA transcripts from narG, which encodes a subunit of the nitrate 
reductase, and narX, an inactive fused nitrate reductase downstream of 
narK2 in a shared operon, have been detected in lungs of patients with TB 
(4, 9, 10), and RNA transcripts encoding the nitrate transporter, narK2, 
were elevated in the lungs of Mtb infected mice (11). Thus, mycobacterial 
nitrate reduction likely occurs in the infected host. 
Our laboratory recently converted our culture system for primary 
human macrophages from conventional gas-phase conditions of 21% O2, 
5% CO2 to 10% O2, 5% CO2 on the grounds that 10% O2 is physiologic 
for tissue macrophages (12). To our surprise, infection of the 
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macrophages in vitro with wild type Mtb under 10% oxygen resulted in 
extensive accumulation of nitrite in the supernatant. Evidence will be 
presented elsewhere that macrophages were not the source of nitrite in 
this system. In contrast, as shown below, Mtb’s NarG was the source, 
despite the non-hypoxic level of oxygen in the gas phase.  
Wayne has proposed that nitrate respiration supports the 
establishment of a non-replicating persistent state (NRP) in response to 
hypoxia (13). We hypothesized that Mtb lacking the capacity for nitrate 
respiration might demonstrate an impaired entrance into NRP and 
therefore remain more susceptible to drugs that target replicating Mtb. 
The goal of the present study was to assess the contribution of nitrate 
respiration to Mtb’s sensitivity to the drugs isoniazid (INH), ethambutol, 
streptomycin and rifampicin. Compared to wild type Mtb, narG-deficient 
Mtb, which is unable to produce nitrite, was selectively hyper-susceptible 
to INH, as well as hyper-resistant to hydrogen peroxide. INH requires 
oxidative activation by the mycobacterial catalase/peroxidase KatG in 
order become cidal. The resultant isonicotinoyl radical adducts with 
cellular pyridine nucleotides and potently inhibits InhA, a member of type 
II fatty acid synthesis pathway involved in cell wall mycolic acid 
biosynthesis (14, 15). These findings imply that the action of INH on Mtb 
may be blunted by nitrite contributed by the host, the pathogen or both.  
 
Results  
Nitrate respiration enhanced mycobacterial resistance to isoniazid within 
primary human macrophages. 
We observed no difference in survival of wild type (Wt Mtb) and 
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narG-deficient Mtb (NarG Mtb) during infection of primary human 
macrophages under 10% O2 and 5% CO2 (Figure 1a). During the course 
of infection, large quantities of nitrite arose in the supernatant of 
macrophages infected with wild type Mtb, which was not observed in the 
supernatants of macrophages infected with narG-deficient Mtb (Figure 
1b). To test the role of nitrate reduction on the susceptibility of Mtb to 
antibiotics, we infected macrophages with wild type, narG-deficient and 
complemented strains (NarGc Mtb) and treated the cultures with drugs. 
Mtb deficient in narG was hyper-susceptible to INH, with a 10-fold 
decrease in the MBC99 compared to wild type (Figure 1c-d). In contrast, 
narG made no observable difference to the antibacterial actions of 
streptomycin, rifampicin or ethambutol on Mtb within macrophages 
(Supplementary Figure 1a-f, see Appendix 2).  
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Figure 1. Effect of nitrate respiration on mycobacterial resistance to 
isoniazid within primary human macrophages. (A) Survival of wild 
type and narG-deficient (NarG) Mtb within macrophages (MOI: 0.1, 
corresponding to 10,000 bacteria). (B) Nitrite levels arising in the 
supernatant of macrophages 3 days after infection with wild type Mtb (Wt 
Mtb), NarG Mtb and the complemented strain (NarGc Mtb) (MOI: 5). (C) 
Susceptibility of Mtb to INH within infected macrophages (MOI: 0.1) 
over 3 days. Means ±SEM from one experiment representative of 3 
independent experiments using cells from different donors. (D) As in (C), 
pooling results from the 3 donors (means ± SEM) at a single INH 
concentration administered to the culture for 3 days (0.1 μg mL-1). The p 
value was determined by an unpaired t test.  
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Addition of nitrite reversed the hyper-susceptibility of narG-deficient Mtb 
to isoniazid. 
The hyper-susceptibility of narG-deficient Mtb to INH may have 
resulted from loss of the metabolic energy generated by nitrate reduction 
or from failure to produce nitrite. To distinguish between these 
possibilities, we added exogenous nitrite to the medium of infected 
macrophage cultures treated with INH. Because the standard culture 
medium consisted of 40% human plasma and 60% RPMI 1640, it 
contained high concentrations of nitrate. Therefore, to limit the 
accumulation of nitrite produced by wild type Mtb, we replaced the 
medium immediately prior to infection with a low-nitrate medium (to 
minimize perturbation we refrained from washing the cells thoroughly; 
thus, medium exchange was not complete). Addition of exogenous nitrite 
enhanced bacterial survival in the presence of INH in a dose-dependent 
manner (Figure 2a-c). That this effect was less striking in the case of wild 
type Mtb was likely due to residual nitrate in the medium, allowing for 
low-level nitrite production (Figure 2a). 
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Figure 2. Impact of exogenous nitrite on the hyper-susceptiblity of 
narG-deficient Mtb to isoniazid. (A, B) The effect of nitrite on the 
survival of (A) wild type or (B) narG-deficient (NarG) Mtb within INH-
treated infected macrophages (MOI: 0.1). The standard culture medium 
was replaced with low-nitrate medium. Where indicated by the dashed 
lines, exogenous sodium nitrite (final concentration 1 mM) was added to 
the culture medium along with the indicated concentrations of INH. CFU 
were harvested 3 days later. (C) Survival of wild type and narG-deficient 
(NarG) Mtb within macrophages treated with increasing concentrations of 
nitrite in the presence of a single concentration of INH (0.1 μg mL-1). The 
standard culture medium was replaced with low-nitrate medium and 
exogenous sodium nitrite was added at the indicated final concentrations. 
Each result is representative of at least two independent experiments 
(means ± SEM). 
 
Mtb deficient in narG Mtb was hyper-susceptible to isoniazid in axenic 
culture. 
Mtb respires nitrate when infecting human macrophages under 10% 
oxygen, but in axenic culture, as noted, nitrate respiration is barely 
detectable until oxygen is lowered to 1% or less. This implied that within 
macrophage phagosomes, the functional level of oxygen perceived by 
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Mtb was far lower than the level present in the gas phase. The nitrate 
reductase assay is routinely used in clinical laboratories to identify drug 
resistant Mtb (16). Although the assay is carried out under room air (21% 
oxygen), nitrate reductase activity is measured at the end of a prolonged 
incubation period, which may indicate that the medium in which Mtb is 
incubated becomes hypoxic. Alternatively, while aerobic cultures of Mtb 
do not express the nitrate transporter, narK2, nitrate may gradually diffuse 
across the plasma membrane and be reduced to nitrite. In order to test the 
role of nitrate respiration in Mtb’s susceptibility to INH in the absence of 
macrophages, we cultured wild type and narG-deficient Mtb in 21% 
oxygen or 1% oxygen. No measurable survival differences were observed 
for the two strains in room air in response to isoniazid, streptomycin, or 
rifampicin (Figure 3a-c). Under 1% oxygen, however, the survival of 
narG-deficient INH-treated Mtb dropped by 2-3 log10 as compared to wild 
type and complemented strains (Figure 3d), which was due to the 
induction of the nitrate reductase system. Next, we examined survival as a 
function of time rather than concentration. A single application of INH led 
to a drop of 2 log10 in CFU of the narG-deficient strain over 9 days, while 
the CFU of the wild type and complemented strains remained constant 
(Figure 3e). Exogenous nitrite enhanced the survival of the narG-deficient 
and wild type strains cultured in the absence of nitrate and treated with 
INH (Figure 3f).  
Following INH treatment and its subsequent activation by KatG, 
Mtb induces the expression of kasA and ahpC (17). The narG-deficient 
strain demonstrated greater induction of kasA and ahpC RNA transcripts 
than the wild type strain in response to 0.1 μg mL-1 INH, and induction 
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was attenuated following treatment with nitrite (Figure 3g). INH requires 
oxidative activation by the mycobacterial catalase/peroxidase KatG in 
order to become bioactive. These results suggest that when presented with 
the same concentration of INH under conditions that could sustain nitrate 
respiration by wild type Mtb, narG-deficient Mtb converted a larger 
proportion of the INH prodrug to its active form than wild type Mtb. This 
implied that the production of nitrite during respiration of nitrate by wild 
type Mtb might partially inhibit KatG.  
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Figure 3. Impact of narG-deficiency on susceptibility of Mtb to 
isoniazid in axenic culture. (A-C) Survival of wild type and narG-
deficient Mtb in the presence of the indicated concentrations of (A) 
isoniazid, (B) rifampicin or (C) streptomycin in 21% oxygen over 5 days, 
initial (OD 0.1). Published MICs are provided for reference (46). (D, E) 
Survival of wild type, narG-deficient (NarG) and complemented (NarGc) 
strains cultured in 1% oxygen (D) for 3 days with the indicated 
concentrations of INH or (E) as a function of time over 9 days with 0.1 μg 
mL-1 INH. (F) Survival of wild type and narG-deficient Mtb incubated 
with increasing concentrations of exogenous nitrite or one fixed dose of 
nitrate, as indicated, over 3 days in 1% oxygen with 0.1 μg mL-1 INH. 
Results for (A-F) are means ± SEM representative of 2 independent 
experiments. (G) Expression of transcripts of ahpC and kasA by wild type 
and narG-deficient Mtb treated with 0.1 μg mL-1 INH and 5 mM nitrate 
for 16 hrs at 1% oxygen relative to 16S RNA. Where indicated, 2.5 mM 
nitrite was also added. Bars indicate means ± SEM from 3 independent 
experiments analyzed by unpaired t tests.  
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Figure 3 (continued) 
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narG-deficient Mtb was not hyper-susceptible to treatment with 
ethionamide.  
To further investigate the role of KatG in mediating the hyper-
susceptibility of narG-deficient Mtb to INH, we infected human 
macrophages with Mtb and treated the cultures with ethionamide (ETH). 
ETH and INH are close chemical analogues. Both are prodrugs that when 
activated inhibit the same target, InhA. However, ETH is activated by the 
monoxygenase EtaA rather than by KatG (18, 19). Survival of wild type 
and narG-deficient Mtb treated with ETH within infected human 
macrophages did not differ (Figure 4a). Therefore, the INH susceptibility 
of narG-deficient Mtb is unlikely to be due to differential dependence on 
InhA and may instead be due to differences in the activation of INH by 
KatG.  
 
Nitrate reduction enhanced the lethality of hydrogen peroxide.  
KatG is the mycobacterial catalase peroxidase that is also 
responsible for the cellular activation of INH. Levels of KatG mRNA 
determined by qRT-PCR and KatG protein detected by western blot did 
not differ among wild type, narG-deficient and complemented strains of 
Mtb (Supplementary figure 2b-c, see Appendix 2). Moreover, we were 
unable to measure differences in the extent of KatG dependent oxidation 
of INH via nitroblue tetrazolium staining of polyacrylamide gel 
electrophoregrams of lysates obtained from the three strains (data not 
shown). Nonetheless, to help assess whether the catalytic activity of KatG 
might differ between wild type and narG-deficient Mtb, the strains were 
incubated for several hours with nitrite or nitrate at 1% oxygen to allow 
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for nitrate respiration and then treated with hydrogen peroxide, the natural 
substrate of KatG. We reasoned that if the activity of KatG were 
attenuated by nitrite, the wild type and complemented strains might be 
more susceptible to hydrogen peroxide than narG-deficient Mtb. In 
accord with this hypothesis, narG-deficient Mtb was more resistant to 
hydrogen peroxide than the other two strains (Figure 4b). The enhanced 
mycobactericidal effect of hydrogen peroxide on wild type Mtb incubated 
with nitrate was also observed following the addition of increasing 
concentrations of exogenous nitrite in the absence of nitrate (Figure 4c 
and Supplementary Figure 2b, see Appendix 2).  
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Figure 4. Impact of narG-deficiency on susceptibility of Mtb to 
ethionamide and hydrogen peroxide. (A) Survival of wild type and 
narG-deficient Mtb within infected primary human macrophages (MOI: 
0.1) treated with the indicated concentrations of ethionamide for 3 days at 
10% oxygen. (B) Survival of Mtb in axenic culture treated with nitrate or 
nitrite for 8 hours in 1% oxygen, to allow for nitrate respiration to occur, 
and then treated with hydrogen peroxide (500 μM) and incubated in 1% 
oxygen overnight (initial OD580: 0.1). These are pooled data from 2 
independent experiments and were analyzed by an unpaired t test. (C) 
Survival of wild type, narG-deficient (NarG Mtb) and complemented 
strains (NarGc Mtb) (initial OD580: 0.1) following treatment with both 
hydrogen peroxide (500 μM) and increasing concentrations of nitrite as 
indicated. Individual experiments representative of at least 2 independent 
experiments. Bars indicate means ± SEM. 
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Discussion 
Herein we report that deficiency of narG increases the 
susceptibility of Mtb to INH and decreases its susceptibility to hydrogen 
peroxide. Prior to this work, the knockout of only one gene, cydC, had 
been reported to increase the susceptibility of Mtb to INH (20). The 
mechanism in the present study most likely involves nitrite-mediated 
impairment of the activity of KatG that takes place when wild type Mtb 
reduces nitrate to nitrite, which is absent in narG-deficient Mtb. Although 
nitrate is usually omitted from mycobacterial culture media, it is a 
physiologic constituent of human body fluids. Although Mtb does not 
reduce nitrate to nitrite in axenic culture unless the culture is hypoxic, we 
found that Mtb does reduce nitrate to nitrite when cultured within 
macrophages at physiologic oxygen tensions. Thus, phenotypic INH 
resistance arising from Mtb’s nitrate respiration is likely to occur in the 
Mtb-infected host. 
Interactions of catalase and other peroxidases with nitrite are 
complex (21-24). When we incubated Mtb with nitrite, lysed the cells, 
separated the proteins by non-reducing polyacrylamide gel electrophoresis 
and incubated the gel with INH and a tetrazolium dye as described (25), 
we did not see impairment in the activity of catalase compared to lysates 
from Mtb not exposed to nitrite (not shown). However, the biochemical 
environment within intact mycobacteria differs markedly from that of gels 
in room air, and tetrazolium is not a physiologic oxidant for INH. 
Moreover, katG mutations that cause INH resistance do not necessarily 
impact the rate of INH-NAD adduct formation by KatG relative to wild 
type Mtb, pointing to the potential for dissociation between the functional 
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effects of KatG mutations and the results of biochemical assays for KatG 
activity (26-29).  
The following evidence supports the hypothesis that nitrite 
interfered with the INH-activating function of catalase in the intact 
mycobacterium: Mtb deficient in narG was both more susceptible to INH 
and more resistant to hydrogen peroxide than wild type Mtb. Second, 
narG-deficient Mtb was not hyper-susceptible to treatment with ETH. 
Third, compared to wild type and complemented strains, narG-deficient 
Mtb demonstrated higher expression of ahpC and kasA, two genes 
induced by treatment with INH, and their expression was reduced by the 
addition of nitrite to the cell culture. Taken together, these results suggest 
that Mtb lacking narG achieves greater KatG-mediated activation of INH 
than wild type Mtb. Lastly, in agreement with this hypothesis, narG-
deficient Mtb better resisted treatment with hydrogen peroxide. The 
mutation of genes other than katG can also cause INH resistance. For 
example, mutations that impair the catalytic activities of Ndh, a type II 
NADH dehydrogenase, and MshA and MshC, which contribute to 
mycothiol biosynthesis, can cause INH resistance. However, inactivating 
mutations in any one of these genes also cause ETH resistance (30-32), 
which was not observed in this study. 
Nitric oxide or nitrite at low pH, which generates nitric oxide (33), 
can potentiate the bactericidal activity of hydrogen peroxide towards E. 
coli (2, 21, 34, 35).  However, to our knowledge, this is the first report 
that nitrite at neutral pH can synergistically enhance the bactericidal 
action of hydrogen peroxide. Production of hydrogen peroxide by 
phagocytic cells is an important component of host antibacterial defense 
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(36). Mycobacterial nitrate respiration may enhance the lethality of host 
reactive oxygen species in vivo. This may result from inhibition of KatG 
by nitrite or from inhibition of a variety of antioxidant defense proteins, 
including KatG, by products more reactive than nitrite to which nitrite can 
give rise. In E. coli, nitrate reductase is an important source of species 
reactive enough to nitrosylate proteins, as evidenced by an 80% reduction 
in protein S-nitrosylation in narG-deficient as compared to wild type 
bacteria (37-39). Rhee et al. identified 29 mycobacterial proteins that 
were S-nitrosylated when Mtb was treated with nitrite at low pH, 
including KatG (40). In addition, heme peroxidases such as KatG oxidize 
nitrite to more reactive species, such as nitrogen dioxide (•NO2) and nitryl 
chloride (NO2Cl) (21-24).  
INH is widely reported to lose mycobactericidal activity when Mtb 
is cultured in conditions that prevent it from replicating. However, when 
the oxygen in an axenic, nitrate-containing culture of Mtb was reduced 
below 1%, narG–deficient Mtb, which was not replicating, became highly 
INH sensitive. We confirmed that effect and demonstrated its reversal 
with exogenous nitrite. To the extent that a relevant source of nitrite for 
Mtb residing in a macrophage in the human host may be Mtb itself, the 
question arises whether the cidality of INH for non-replicating narG-
deficient Mtb could be phenocopied in non-replicating wild type Mtb by 
an inhibitor of Mtb’s nitrate transporter or nitrate reductase. If so, such 
agents might significantly reduce the time required to cure latent TB with 
INH or active TB with INH-containing regimens, reducing the incidence 
of emergent drug resistance associated with incomplete treatment (41, 
42). InhA is essential to aerobically and perhaps also hypoxically cultured 
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mycobacteria as two compounds that targeted both InhA as well as fatty 
acid synthase type 1 were cidal to non-replicating Mtb (43). Nevertheless, 
it remains unclear whether the reduced survival of narG-deficient Mtb 
treated with INH resulted only from the inactivation of InhA or by 
inhibition of additional mycobacterial target(s). A mechanistic 
understanding of the hyper-susceptibility of narG-deficient Mtb to INH 
may reveal new INH target(s) amenable to inhibition by other 
compounds. 
 
Methods  
Isolation and differentiation of primary human monocytes 
Isolation of human monocytes and their differentiation into 
macrophages was as described (12). In brief, heparinized peripheral blood 
was collected by venipuncture from healthy human donors who provided 
informed consent under an IRB approved protocol. Peripheral blood 
mononuclear cells were first isolated by centrifugation of whole blood 
over Ficoll-Paque (GE Healthcare). The buffy coats were collected and 
monocytes were isolated by positive selection using magnetic beads 
conjugated to anti-CD14 antibodies (Milteyi Biotec). Following isolation, 
the human monocytes were plated at a density of 500,000 cells ml-1 per 
well of a 96 well plate. The culture medium consisted of 60% RPMI 
1640, supplemented with 1% glutamax, 40% human plasma and GMCF 
and TNFα (0.5 ng ml-1 each). 30% of the total culture volume was 
replaced with fresh medium and cytokines every 3 to 4 days.  Replacing 
fresh medium was conducted as rapidly as possible in room air before the 
cells were placed back in the low oxygen incubator. Differentiation of the 
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monocytes was conducted over 2 weeks in our standard medium at 10% 
O2 and 5% CO2 at 37°C in a humidified atmosphere in a chamber flushed 
with N2 under the control of a PRoOX sensor and ProCO2 regulator 
(BioSpherix). They were then activated with IFNγ (5 ng ml-1) before 
infection with M. tuberculosis the following day at the desired 
multiplicity of infection (MOI).  
 
Preparation of Mtb and infection of human macrophages with 
Mycobacterium tuberculosis 
M. tuberculosis H37Rv was grown in Middlebrook 7H9 broth 
supplemented with 0.2% glycerol, 0.5% BSA, 0.2% dextrose and 0.085% 
NaCl with 0.05% Tween 80. The narG–deficient and complemented 
strains were generated as described (44). Cultures were started with 1 mL 
stock originally frozen at -80°C in log phase and then grown over 4 to 5 
days to optical densities (OD) of 0.5-1.25 before the start of an 
experiment. A single-cell suspension was generated by centrifugation at 
120 g for 10 minutes. For macrophages infection, roughly 200x106 
bacteria were centrifuged, in order to be able to observe a pellet. The 7H9 
was completely removed and the cells were washed with PBS. The 
bacteria were then resuspended in culture medium and the desired number 
of Mtb was added to the macrophage culture.  
Certain experiments required that we remove the nitrate-containing 
medium from the cell culture. In this case, 1 day prior to infection the 
cells were washed with room temperature PBS 3 times and a low nitrate 
formulation of DMEM with 10% human plasma was added along with 0.5 
ng mL-1 GMCSF and TNFα and 5 ng mL-1 IFNγ. 
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Measurement of nitrite  
Nitrite levels produced in the co-culture supernatants of infected 
macrophages were measured by the Griess assay. Briefly, 100 μl of 
supernatant was removed and to this were added 50 μl of 2% 
sulfanilamide with 5% phosphoric acid and 50 μl of 0.2% N-1-
napthylethylenediamine dihydrochloride. Nitrite standards were prepared 
in the same medium used to culture the macrophages. Absorbance was 
measured at 550 nm immediately after addition of the reagents to the 
supernatant samples.  
 
Treatment of infected macrophages 
Macrophages were incubated with Mtb at the indicated MOI for 4-5 
hours under 10% oxygen. The supernatant was removed and the 
macrophages were washed 3 times with room temperature PBS to remove 
extracellular bacteria. Fresh medium was added to the cells, followed by 
the addition of nitrite, nitrate and/or an antimycobacterial drug such as 
INH.  The cultures were then returned to the low oxygen incubator and 
incubated for a subsequent 3 days with the desired compound. Drugs were 
freshly dissolved before each experiment in DMSO, except for 
streptomycin, which was dissolved in water. 
 
CFU determination from infected macrophages 
Following incubation with Mtb for 3 days, the macrophages were 
inspected by microscopy to ensure continued confluence and adherence to 
the well. The supernatant was collected and the cells were gently washed 
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3 times with room temperature PBS to wash away remaining compounds. 
Following the wash steps, the cells were again visualized to confirm that 
the monolayer was intact and then lysed by incubation in 0.5% Triton X-
100 for 10 minutes at 37°C. The lysate was serially diluted in 0.1% Triton 
X-100 and plated on Middlebrook 7H11 agar with 10% oleic acid-
albumin-dextrose-catalase (OADC) enrichment (Difco) supplemented 
with 0.5% glycerol. Colonies were enumerated following 3 weeks of 
culture at 37 °C, in 21% O2, 5% CO2.  
 
Treatment of Mtb in axenic culture  
Mtb was added at the indicated OD to 96 well plates in 7H9 broth 
with or without 5 mM nitrate or the indicated concentration of nitrite, 
supplemented with 10 ADNaCl (0.2% glycerol, 0.5% BSA, 0.2% 
dextrose, 0.085% NaCl) and 0.05% Tween 80. The indicated antibiotic 
was added immediately and the plate was incubated in 1% oxygen for 3 
days or at 21% oxygen for 5 days, as indicated. The Mtb was 
resuspended, serially diluted in 0.1% Triton-X 100 and plated for CFU as 
above. Alternatively, for OD measurements, the Mtb was resuspended in 
the culture medium and the absorbance was read at 580 nm on the fifth 
day of incubation with the indicated compound. In the case of exposure to 
hydrogen peroxide, the plate was incubated in 1% oxygen for 8 hours 
with or without 1 mM nitrate or the indicated concentration of nitrite. At 
this point, the indicated concentration of hydrogen peroxide was added 
and the cells were incubated overnight at 1% oxygen before plating for 
CFU. 
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KatG western blot and measurement of KatG dependent oxidation of INH 
A minimum of 4x109 bacteria per condition were suspended in 
7H9, 10% ADNaCl at an OD of 0.2 in the presence or absence of 2.5 mM 
nitrite. Cultures were incubated for 1 day in 1% oxygen. The cultures 
were collected by centrifugation and resuspended in 200 μl of lysis buffer 
containing 50 mM NaPO4, 1 mM PMSF and 4x complete protease 
inhibitor cocktail (Roche). The cells were lysed in a bead-beating 
homogenizer with silica beads 3 times with intermittent incubation on ice. 
The lysate was collected and filter sterilized and concentrated at 4°C to 
~100 μl using Amicon Ultra-0.5 mL centrifugal filters from Millipore 
with a molecular weight cut-off of 3 kDa. Protein concentration was 
measured using the Bio-Rad assay and equal amounts of protein from 
each sample were loaded into 7.5% reducing gels. After electrophoresis, 
proteins were transferred onto a polyvinylidene difluoride membrane, 
blocked with Odyssey blocking buffer from LI-COR Biosciences and 
stained with anti-KatG antibody (obtained through BEI Resources, 
NIAID, NIH: Monoclonal Anti-Mycobacterium tuberculosis KatG, gene 
Rv1908c, clone IT-57 (CDA4) (culture supernatant), NR-13793) and anti-
DlaT antibody (1:1000) and then visualized with fluorophore-coupled 
secondary antibodies (45). To test the degree of KatG dependent 
oxidation of INH, 50 μg of total cell lysate was loaded into 7.5% non-
reducing gels. After electrophoresis, the gel was incubated at room 
temperature for 15 - 30 minutes in 50 μLs of NaPO4 buffer containing 62 
mg INH, and 2 mM nitroblue tetrazolium (NBT) at pH 7 to which 
hydrogen peroxide was added to a final concentration of 800 μM (25). 
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Quantitative PCR of RNA from Mtb growing in macrophages or broth 
culture 
Five million human macrophages were cultured per T25 flask in 
10% oxygen and infected with wild type, narG-deficient or the 
complemented strains of Mtb at an MOI of 40 for 10 hours. Supernatant 
was removed and the monolayer was washed 2 times with room 
temperature PBS. Trizol (2 mL) was added to each flask and the cells 
were detached using a rubber policeman. For broth cultures, at least 
2.5x109 bacteria per condition were incubated in 1% oxygen for 3 days 
with or without 2.5 mM nitrite and 0.1 μg mL-1 INH. Then an equal 
volume of 5M GTC buffer containing 5M guanidine thiocyanate, 25 mM 
sodium citrate, 20 mM N-lauryl-sarcosine, 0.7% v/v β- mercaptoethanol, 
was added. The bacteria were pelleted by centrifugation and 1 mL of 
Trizol was added per sample. The suspension was beaten with silica 
beads, 3 times. RNA was extracted using an RNeasy kit (Qiagen) in 
accordance with the manufacturer’s instructions with the exception that 
off column DNAse digestion was performed for 2 hrs at 37 °C. To 
generate cDNA, total RNA (900 ng) was reverse transcribed using the 
GeneAmp RNA PCR Kit (Applied Biosystems). Quantitative RT-PCR 
was performed using gene specific primers (Life Technologies) and the 
SuperScript III Platinum Two Step qRT-PCR Kit (Life Technologies) 
with a 7900HT Fast Real Time PCR System (Applied Biosystems). Each 
experiment contained experimental triplicates. All reported values were 
within the linear range of the primers and the experimental results were 
normalized to 16S rRNA values.  
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Statistical analysis 
Statistical analysis was performed as indicated in the figure legends 
using the standard statistical software Prism version 5.0f for Macintosh, 
GraphPad Software, San Diego California USA 
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CHAPTER 4 
CONCLUSIONS 
 
Within Mtb-infected humans, nitrite levels rise to such substantial 
levels as to be measured within the plasma (1, 2). This nitrite is likely a 
product of the host’s immune response as well as Mtb’s hypoxic 
respiratory pathway. However, these enzymatic processes are inversely 
regulated by oxygen tension (3, 4). Therefore, in the host whether Mtb 
faces normoxia or hypoxia it will encounter nitrite and the RNS that 
generate or arise from it. That Mtb resides within hypoxic tissue in the 
human host is inferred from experiments with infected model hosts, which 
develop hypoxic lesions containing Mtb (5-7). In addition, lung tissue 
resected from patients with TB contains RNA transcripts that encode 
proteins essential to nitrate respiration (8, 9). Therefore, Mtb likely 
respires nitrate within the human host. 
 The majority of infected individuals will never eradicate Mtb, 
though most successfully sequester the pathogen. Subpopulations of 
mycobacteria residing within the human host are thought to enter into a 
dormant, non-replicating state and to survive for the lifetime of the host 
(10). Persisting mycobacteria will serve as a nidus for disease reactivation 
and infection of new hosts (10, 11). The extent to which nitrate respiration 
contributes to Mtb’s persistence in vivo remains unknown. However, the 
host is comprised of heterogeneous microenvironments in which Mtb may 
transiently be exposed to concentrations of oxygen sufficient to support 
active replication (12). While renewed growth may be advantageous and 
  87 
contribute to the colonization of new hosts, ill-timed growth may disrupt 
the dynamic equilibrium that exists between the pathogen and host and 
compromise bacterial dissemination. Once a granulomatous lesion 
containing Mtb erodes into a bronchus, droplet nuclei containing Mtb are 
expelled from the diseased individual to enter and infect a naïve host (13). 
Therefore, in the setting of sustained normoxia, Mtb-derived nitrite may 
limit untimely growth and provide a store of metabolic energy to 
provision the colonization of naïve hosts.  
Nitrate respiration regulated the expression profile of genes that are 
also regulated by exposure of Mtb to pH 5.5, hydrogen peroxide, nitric 
oxide, hypoxia, iron-depleted medium and residence within mouse 
macrophages. Therefore, nitrate respiration may support the survival of 
Mtb faced with hostile host stresses. In fact, this has already been 
demonstrated for Mtb exposed to low pH, RNS (14) and sudden 
anaerobiosis (15). We have reported that the combination of Mtb-derived 
nitrite and hydrogen peroxide is more lethal to Mtb than treatment with 
hydrogen peroxide alone (Cunningham-Bussel, manuscript in preparation, 
see chapter 2). However, while short incubations with nitrite synergized 
with hydrogen peroxide to kill Mtb, longer incubations seemed to 
promote the survival of hydrogen peroxide treated Mtb, although this 
remains to be confirmed (data not shown). Therefore in regards to 
hydrogen peroxide, nitrite may exert opposing effects depending both 
upon the concentration and length of exposure of Mtb to nitrite prior to 
treatment with hydrogen peroxide.  
We also observed that in the absence of nitrate respiration, as 
compared to bacteria that continued to respire nitrate, Mtb became hyper-
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susceptible to INH. Therefore, inhibitors of the nitrate reductase or 
nitrate/proton symporter narK2 may synergize with INH to significantly 
reduce the length of time required to treat TB. That INH remained 
bactericidal even under non-replicating conditions suggested that the 
hyper-susceptibility of narG-deficient Mtb to INH might have been due to 
the inhibition of a cellular protein(s) other than the recognized protein 
target of INH, InhA. Furthermore, regardless of any synergy with INH, 
nitrate respiration may prove to more broadly support the survival of Mtb 
in vivo. Therefore, compounds that prevent nitrate respiration may prove 
to be valuable additions to the arsenal of antitubercular antibiotics.  
 
Future directions 
 
Future experiments will need to first address whether nitrate 
respiration benefits the survival of Mtb in a model organism. Similarly, 
the observation that nitrate respiration allows Mtb to resist INH should 
also be tested in vivo. High-throughput screening of chemical libraries 
against axenic cultures of Mtb may identify novel compounds that inhibit 
the mycobacterial nitrate reductase and nitrate/proton symporter narK2. In 
addition, it may be possible to identify the protein target(s) of INH in non-
replicating Mtb lacking a functional nitrate reductase by screening for 
spontaneous revertants of narG-deficient Mtb that lose their hyper-
susceptibility to INH. Alternatively, this may be accomplished by 
screening a library of transposon insertion mutants generated in narG-
deficient Mtb for variants that have altered susceptibility to INH. The 
mutants that demonstrate either increased or reduced sensitivity may 
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contain transposon insertions in genes that regulate the susceptibility of 
non-replicating Mtb to INH.        
In vivo experiments to determine the impact of nitrate respiration 
on Mtb within the host will require a model organism that develops 
hypoxic, TB-associated lesions, such as the guinea pig, rabbit or macaque 
(5). These organisms better mimic human tissue pathology as compared to 
the standard mouse model, which is not hypoxic (5-7). Recently, an 
alternative mouse model was reported to develop hypoxic lesions in 
response to infection with Mtb (16). This mouse strain may therefore be a 
more suitable model system in which to investigate the contribution of 
nitrate respiration to the persistence of Mtb in vivo.  
Both the host and pathogen are potential sources of nitrite in vivo. 
Therefore, it will be important to determine the amount of nitrite 
individually produced by the host and pathogen and to selectively abolish 
these catalytic activities during the course of infection. The production of 
host-nitrite can be limited by the use of selective or non-selective NOS 
inhibitors (17, 18) or greatly repressed by genetic deletion of iNOS (19). 
Pathogen derived nitrite production is abolished by the genetic deletion of 
narG (4). In addition to the selective abrogation of nitrite generated by the 
host or pathogen, nitrite can be supplemented by adding nitrate or nitrite 
to the diet of infected model hosts (20, 21). Dietary nitrate and nitrite 
supplementation can greatly increase the concentration of plasma and 
tissue nitrite as well as the concentration of tissue S-nitrosylation (20). 
Therefore, an additional experiment might involve infection of iNOS 
deficient host organisms with narG-deficient Mtb followed by the 
supplemental administration of exogenous nitrate or nitrite, which may 
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contribute to determining the impact of nitrite on Mtb in vivo.  
Mycobacterial nitrate respiration caused a non-heritable resistance 
to INH, which remains mechanistically unexplained. Nitrite and the RNS 
that arise from it are known to post-translationally modify cellular 
proteins and interfere with their function (22-25). Drug resistance is often 
attributed to the acquisition of heritable genetic mutations that protect 
bacterial populations from cidal compounds. However, non-heritable 
survival has also been described to account for the persistence of 
genetically susceptible bacteria treated with bactericidal antibiotics (26, 
27). Mtb persists in vivo, despite treatment with antimycobacterial 
antibiotics such as INH (28). Therefore, despite an underlying genetic 
sensitivity to INH, the survival of subpopulations of Mtb treated with INH 
may be due to the resistance afforded by mycobacterial nitrate respiration. 
Nitrite is highly diffusible and therefore could non-heritably manipulate 
array of cellular targets across a population of bacteria. Therefore, INH 
resistance is but one functional consequence of mycobacterial nitrate 
respiration; others likely remain to be characterized.  
Nitrite has previously been demonstrated to regulate mammalian 
gene expression (23, 29). However, we did not observe any impact of 
mycobacterial nitrate respiration on the transcriptome of Mtb infected 
human macrophages. However, unlike the transcriptional profiles of 
groups of genetically identical mice or bacteria, the transcriptional profile 
of Mtb infected macrophages was analyzed using RNA collected from 
three genetically dissimilar individuals. We propose that the lack of an 
observable impact of nitrate respiration on the transcriptome of infected 
primary human macrophages may be due the reportedly variable gene 
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expression that exists between unrelated humans (30).  
In summary, we have demonstrated that mycobacterial nitrite 
reduction impacts a variety of previously described mycobacterial cellular 
processes. However, we anticipate that Mtb-derived nitrite broadly 
impacts not only the cellular processes of Mtb itself, but also the host. 
Nitrate respiration may therefore play a central role in the interaction 
between the host and mycobacterial pathogen, the full extent of which 
remains to be characterized.  
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Supplementary Figure 1. iNOS was not detected within Mtb-infected 
primary human macrophages. Macrophages were either infected with 
Mtb (MOI: 5, indicated by a “+” sign) or remained uninfected for 3 days 
at 10% oxygen. Results are shown for 6 individual donors. Lysates were 
separated by reducing SDS polyacrylamide gel electrophoresis and probed 
with anti-iNOS antibody (Santa Cruz Biotechnology sc-8310) and anti-β-
actin (abcam 8226). The positive control (+ con) was generated by 
lipofectamine-assisted transfection of HEK293 cells with a pcDNA3.1 
plasmid construct containing human iNOS. To generate the negative 
control, HEK293 cells were transfected with an empty plasmid.  
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Supplementary Figure 2. Consumption of exogenous ATP added to 
cell lysates from nitrite treated or untreated bacterial cultures. Wt 
Mtb was incubated in the presence or absence of 2.5 mM nitrite for 3 days 
in 1% oxygen; cell lysates were incubated for 20 minutes at room 
temperature to allow for the complete metabolism of endogenous ATP. 
Reagent ATP (10 μM) was then added to the cell lysates and ATP content 
measured at intervals. Results are from 1 experiment representative of 3. 
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Supplementary Figure S3. Average expression of narK2 by untreated 
and nitrate treated wild type Mtb. Means ± SD, n=3 independent 
experiments. The p value was determined by an unpaired t test. 
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Supplementary Table 1. Genes significantly induced by nitrate. (pcorr 
<0.05), (n=3) Supplementary Table 1
Gene ID Gene
RATIO 
(Nitrate/Untreated) p corr <0.05
Rv2780 ald 9.38 2.58E-03
Rv1994c cmtR 4.22 2.39E-02
Rv1464 csd 28.91 2.72E-04
Rv3743c ctpJ 5.82 4.23E-03
Rv3019c esxR 6.10 3.49E-03
Rv3020c esxS 6.86 1.28E-03
Rv2590 fadD9 5.04 3.42E-02
Rv0752c fadE9 4.23 3.34E-02
Rv1909c furA 7.74 2.41E-03
Rv2384 mbtA 5.65 4.61E-03
Rv2383c mbtB 30.00 5.59E-04
Rv2380c mbtE 13.40 1.02E-02
Rv2386c mbtI 12.52 3.40E-05
Rv2385 mbtJ 4.85 5.07E-03
Rv3206c moeB1 6.42 4.96E-02
Rv0747 PE_PGRS10 4.56 7.39E-03
Rv0834c PE_PGRS14 7.11 1.94E-02
Rv0978c PE_PGRS17 11.21 1.19E-05
Rv2615c PE_PGRS45 6.30 1.07E-02
Rv3746c PE34 7.84 3.40E-05
Rv1402 priA 6.01 1.22E-03
Rv0142 Rv0142 6.16 1.80E-03
Rv0398c Rv0398c 3.77 2.51E-02
Rv0465c Rv0465c 4.86 3.26E-02
Rv0575c Rv0575c 10.3 5.67E-06
Rv0841 Rv0841 3.91 4.91E-02
Rv1049 Rv1049 6.40 1.09E-03
Rv1050 Rv1050 3.90 4.84E-02
Rv1057 Rv1057 4.46 2.16E-02
Rv1375 Rv1375 9.53 2.35E-03
Rv1403c Rv1403c 15.91 2.12E-07
Rv1405c Rv1405c 14.53 4.71E-05
Rv1461 Rv1461 34.70 1.71E-03
Rv1578c Rv1578c 3.83 4.89E-02
Rv1670 Rv1670 4.18 3.09E-02
Rv1671 Rv1671 4.40 2.39E-02
Rv1767 Rv1767 4.05 3.51E-02
Rv1907c Rv1907c 4.14 2.08E-02
Rv1986 Rv1986 3.93 1.32E-02
Rv2324 Rv2324 4.03 3.58E-02
Rv2616 Rv2616 100.96 1.00E-11
Rv2617c Rv2617c 137.41 4.23E-10
Rv2618 Rv2618 26.9 4.08E-04
Rv2619c Rv2619c 20.75 3.11E-05
Rv2621c Rv2621c 21.63 1.78E-06
Rv2622 Rv2622 10.26 1.21E-06
Rv2650c Rv2650c 5.21 6.03E-03
Rv2651c Rv2651c 4.00 2.39E-02
Rv2729c Rv2729c 4.28 1.14E-02
Rv2781c Rv2781c 6.21 7.53E-04
Rv3289c Rv3289c 8.99 3.29E-04
Rv3402c Rv3402c 6.94 2.36E-04
Rv3403c Rv3403c 4.70 2.51E-02
Rv3832c Rv3832c 6.02 2.94E-02
Rv3839 Rv3839 28.77 4.23E-10
Rv3840 Rv3840 4.57 1.05E-02
Rv3288c usfY 6.32 7.30E-03
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Supplementary Table 2. Genes significantly repressed by nitrate. (pcorr 
<0.05), (n=3) Genes labeled with an asterix are members of the DOS 
regulon as defined by (20).  Supplem ntary Table 2
Gene ID Gene
RATIO 
(Nitrate/Untreated) p corr <0.05 Gene ID Gene
RATIO 
(Nitrate/Untreated) p corr <0.05
* Rv0569 Rv0569 0.06 4.01E-10 Rv2917 Rv2917 0.31 0.0431
* Rv2007c fdxA 0.05 4.67E-10 Rv0934 pstS1 0.27 0.0475
* Rv2627c Rv2627c 0.06 7.49E-10 Rv3628 ppa 0.30 0.0475
* Rv2626c hrp1 0.06 1.08E-09 Rv0935 pstC1 0.30 0.0476
* Rv3841 bfrB 0.05 4.29E-09 Rv0165c mce1R 0.28 0.0492
* Rv0570 nrdZ 0.08 2.76E-08 Rv0867c rpfA 0.28 0.0494
* Rv1733c Rv1733c 0.09 0.000000036 Rv2431c PE25 0.27 0.0494
* Rv2031c hspX 0.07 0.000000192
* Rv2625c Rv2625c 0.09 0.000000408
* Rv1739c Rv1739c 0.10 0.000000643
* Rv2032 acg 0.10 0.00000105
* Rv2628 Rv2628 0.11 0.00000134
* Rv1738 Rv1738 0.10 0.0000014
* Rv0572c Rv0572c 0.12 0.00000188
* Rv2623 TB31.7 0.09 0.00000203
* Rv3134c Rv3134c 0.10 0.00000203
* Rv1997 ctpF 0.11 0.00000272
* Rv2030c Rv2030c 0.09 0.00000429
* Rv3130c tgs1 0.09 0.0000295
* Rv1998c Rv1998c 0.16 0.0000559
* Rv3127 Rv3127 0.08 0.0000559
* Rv2624c Rv2624c 0.15 0.000211
* Rv2029c pfkB 0.09 0.00027
* Rv3131 Rv3131 0.04 0.0018
* Rv3126c Rv3126c 0.18 0.00482
* Rv2006 otsB1 0.21 0.00698
* Rv1996 Rv1996 0.21 0.0076
* Rv1736c narX 0.16 0.00991
* Rv1737c narK2 0.09 0.0358
* Rv2028c Rv2028c 0.15 0.0488
Rv1195 PE13 0.10 0.00000123
Rv0700 rpsJ 0.16 0.000454
Rv2190c Rv2190c 0.17 0.000626
Rv0315 Rv0315 0.18 0.000646
Rv1196 PPE18 0.17 0.00278
Rv0227c Rv0227c 0.20 0.00306
Rv0892 Rv0892 0.19 0.00508
Rv0714 rplN 0.22 0.0052
Rv0237 lpqI 0.22 0.0063
Rv0718 rpsH 0.23 0.00635
Rv2952 Rv2952 0.21 0.00789
Rv2033c Rv2033c 0.22 0.0102
Rv2563 Rv2563 0.23 0.0108
Rv0717 rpsN1 0.25 0.0109
Rv0009 ppiA 0.23 0.0131
Rv1884c rpfC 0.23 0.0148
Rv2564 glnQ 0.25 0.015
Rv2450c rpfE 0.19 0.0209
Rv1886c fbpB 0.18 0.0239
Rv0933 pstB 0.27 0.025
Rv2816c Rv2816c 0.28 0.0269
Rv0719 rplF 0.27 0.0278
Rv1515c Rv1515c 0.30 0.0342
Rv2945c lppX 0.29 0.0359
Rv2959c Rv2959c 0.27 0.0419
Rv2416c eis 0.31 0.0431
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Supplementary Table 3. Genes that are significantly regulated by 
nitrate and no other tested stimuli. (pcorr <0.05) The expression of 
genes regulated only by nitrate and no other stimuli reported in Table 1. 
 
Gene Gene ID
Entrez 
Gene ID
Untreated 
(RPKM)
Nitrate 
(RPKM)
RATIO 
(Nitrate/Un
treated) pcorr <0.05 Function Functional category
Rv0978c PE_PGRS17 885077 0.38 4.25 11.21 0.000012 Function unknown PE/PPE
Rv2781c Rv2781c 888488 4.24 26.37 6.21 0.0008 Function unknown
Intermediary 
metabolism and 
respiration
Rv1402 priA 886716 0.31 1.88 6.01 0.0012 Functions as a helicase within the primosome Information pathways
Rv3743c ctpJ 885106 0.50 2.89 5.82 0.0042 Cation-transporting ATPase
Cell wall and cell 
processes
Rv0237 lpqI 886693 3.11 0.69 0.22 0.0063 Probable conserved lipoprotein
Cell wall and cell 
processes
Rv0747 PE_PGRS10 888662 1.61 7.33 4.56 0.0074 Function unknown PE/PPE, lipid metabolism
Rv2615c PE_PGRS45 888215 1.35 8.50 6.30 0.0107 Function unknown PE/PPE
Rv2563 Rv2563 887516 3.78 0.85 0.23 0.0108 Active transport of glutamine
Cell wall and cell 
processes
Rv0752c fadE9 888684 2.85 12.08 4.23 0.0334 Function unknown Lipid metabolism
Rv1515c Rv1515c 886459 1.94 0.57 0.30 0.0342 Function unknown Conserved hypothetical
Rv2917 Rv2917 887758 1.34 0.42 0.31 0.0431
Function unknown, but 
involved in lipid 
degradation
Conserved 
hypothetical, cell wall 
and cell processes
Rv0841 Rv0841 3205068 9.10 35.58 3.91 0.0491 Function unknown Cell wall and cell processes
Rv0165c mce1R 886818 4.50 1.27 0.28 0.0492
Probable transcriptional 
regulatory protein Mce1R 
(probably GntR-family)
Regulatory proteins
Supplementary Table 3
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Supplementary Figure 1. Effect of nitrate respiration on 
mycobacterial resistance to streptomycin, rifampicin and ethambutol 
within primary human macrophages. (A-C) Survival of wild type, 
narG-deficient (NarG) and complemented strains (NarGc) within 
macrophages (MOI: 0.1, corresponding to 10,000 bacteria) treated with 
the indicated concentrations of (A) rifampicin (B) streptomycin or (C) 
ethambutol over 3 days in 10% oxygen. The results shown in A-C are 
single experiments that are representative of at least two independent 
experiments conducted using cells isolated from at least two distinct 
human donors. (D-F) contain the pooled CFU data from at least two 
independent experiments conducted with cells from at least 2 individual 
human donors shown for one drug concentration as follows: (D) 
rifampicin (0.2 μg mL-1) (E) streptomycin (0.6 μg mL-1) or (F) ethambutol 
(0.1 μg mL-1). Bars indicate means ± SEM. 
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Supplementary Figure 2. Nitrite treatment hyper-sensitized Mtb to 
hydrogen peroxide treatment without an observed difference in the 
expression of katG or a measurably reduced degree of its peroxidase 
activity. (A) The survival of axenic cultures of Mtb (OD 0.1) following 
treatment with the indicated concentration of hydrogen peroxide at 1% 
oxygen incubated overnight with 1 mM nitrite. This is representative of 2 
independent experiments. (B) The mRNA expression of katG by wild 
type, narG -deficient (NarG) and the complemented (NarGc) strains 
within infected human macrophages following incubation for three days 
at 10% oxygen. The given experiment is the pooled result of 2 
independent experiments. (C) Axenic cultures of wild type, narG-
deficient and the complemented strains of Mtb were incubated over one 
day at 1% oxygen and lysed to collect total cell protein. Individual 
proteins from the total cell lysate were separated by native gel 
electrophoresis and KatG and the housekeeping gene DLAT were 
visualized by fluorophore coupled antibody staining. This is 
representative of three independent experiments. Bars indicate means ± 
SEM. 
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